Latent	B-protein
membrane	I-protein
protein	I-protein
1	I-protein
of	O
Epstein-Barr	O
virus	O
interacts	O
with	O
JAK3	B-protein
and	O
activates	O
STAT	B-protein
proteins	I-protein
.	O

Latent	B-protein
membrane	I-protein
protein	I-protein
1	I-protein
(	O
LMP1	B-protein
)	O
acts	O
like	O
a	O
permanently	B-protein
activated	I-protein
receptor	I-protein
of	O
the	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	I-protein
TNF	I-protein
)	I-protein
-receptor	I-protein
superfamily	I-protein
and	O
is	O
absolutely	O
required	O
for	O
B	O
cell	O
immortalization	O
by	O
Epstein-Barr	O
virus	O
.	O

Molecular	O
and	O
biochemical	O
approaches	O
demonstrated	O
that	O
LMP1	B-protein
usurps	O
cellular	O
signaling	O
pathways	O
resulting	O
in	O
the	O
induction	O
of	O
NF-kappaB	B-protein
and	O
AP-1	B-protein
via	O
two	O
C-terminal	B-protein
activating	I-protein
regions	I-protein
.	O

We	O
demonstrate	O
here	O
that	O
a	O
third	O
region	O
encompassing	O
a	O
proline	B-protein
rich	I-protein
sequence	I-protein
within	O
the	O
33	O
bp	O
repetitive	O
stretch	O
of	O
LMP1	B-protein
's	O
C-terminus	B-protein
is	O
required	O
for	O
the	O
activation	O
of	O
Janus	B-protein
kinase	I-protein
3	I-protein
(	O
JAK3	B-protein
)	O
.	O

The	O
interaction	O
of	O
LMP1	B-protein
and	O
JAK3	B-protein
leads	O
to	O
the	O
enhanced	O
tyrosine	O
auto/transphosphorylation	O
of	O
JAK3	B-protein
within	O
minutes	O
after	O
crosslinking	O
of	O
a	O
conditional	O
NGF-R	B-protein
:	I-protein
LMP1	I-protein
chimera	I-protein
and	O
is	O
a	O
prerequisite	O
for	O
the	O
activation	O
of	O
STAT	B-protein
transcription	I-protein
factors	I-protein
.	O

These	O
results	O
reveal	O
a	O
novel	O
activating	O
region	O
in	O
the	O
LMP1	B-protein
C-terminus	B-protein
and	O
identify	O
the	O
JAK	B-protein
/STAT	B-protein
pathway	O
as	O
a	O
target	O
of	O
this	O
viral	B-protein
integral	I-protein
membrane	I-protein
protein	I-protein
in	O
B	B-cell_type
cells	I-cell_type
.	O

The	NULL
EMBO	NULL
Journal	NULL
Vol.18	NULL
No.11	NULL
pp.3064-3073	NULL
,	NULL
1999	NULL
Latent	NULL
membrane	NULL
protein	NULL
1	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
interacts	NULL
with	NULL
JAK3	NULL
and	NULL
activates	NULL
STAT	NULL
proteins	NULL
Olivier	NULL
Gires'~	NULL
,	NULL
Franz	NULL
Kohlhuber	NULL
'	NULL
3	NULL
,	NULL
Ellen	NULL
Kilger	NULL
'	NULL
2	NULL
,	NULL
Matthias	NULL
Baumann'*	NULL
,	NULL
Arnd	NULL
Kieser'~	NULL
,	NULL
Christian	NULL
Kaiser'*	NULL
,	NULL
Reinhard	NULL
Zeidler'*	NULL
,	NULL
Beatrix	NULL
Scheffer	NULL
'	NULL
}	NULL
,	NULL
Marius	NULL
Ueffing'*	NULL
and	NULL
Wolfgang	NULL
Hammerschmidt	NULL
``	NULL
'GSF-National	NULL
Research	NULL
Center	NULL
for	NULL
Environment	NULL
and	NULL
Health	NULL
,	NULL
*Institute	NULL
of	NULL
Clinical	NULL
Molecular	NULL
Biology	NULL
and	NULL
Tumor	NULL
Genetics	NULL
,	NULL
*Department	NULL
of	NULL
Gene	NULL
Vectors	NULL
,	NULL
Marchioninistrasse	NULL
25	NULL
,	NULL
D-81377	NULL
Miinchen	NULL
and	NULL
*Department	NULL
of	NULL
Otorhinolaryngology	NULL
,	NULL
Ludwig-Maximilians-Universitiit	NULL
,	NULL
Marchioninistrasse	NULL
15	NULL
,	NULL
D-81377	NULL
,	NULL
Miinchen	NULL
,	NULL
Germany	NULL
3Corresponding	NULL
author	NULL
e-mail	NULL
:	NULL
hammerschmidt	NULL
@	NULL
gsf.de	NULL
O.Gires	NULL
and	NULL
F.Kohlhuber	NULL
contributed	NULL
equally	NULL
to	NULL
this	NULL
work	NULL
Latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
acts	NULL
like	NULL
a	NULL
permanently	NULL
activated	NULL
receptor	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-receptor	NULL
superfamily	NULL
and	NULL
is	NULL
absolutely	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
immortalization	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Molecular	NULL
and	NULL
biochemical	NULL
approaches	NULL
demonstrated	NULL
that	NULL
LMP1	NULL
usurps	NULL
cellular	NULL
signaling	NULL
pathways	NULL
resulting	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
via	NULL
two	NULL
C-terminal	NULL
activating	NULL
regions	NULL
.	NULL

We	NULL
demonstrate	NULL
here	NULL
that	NULL
a	NULL
third	NULL
region	NULL
encompassing	NULL
a	NULL
proline	NULL
rich	NULL
sequence	NULL
within	NULL
the	NULL
33	NULL
bp	NULL
repetitive	NULL
stretch	NULL
of	NULL
LMPI	NULL
's	NULL
C-terminus	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
Janus	NULL
kinase	NULL
3	NULL
(	NULL
JAK3	NULL
)	NULL
.	NULL

The	NULL
interaction	NULL
of	NULL
LMP1	NULL
and	NULL
JAK3	NULL
leads	NULL
to	NULL
the	NULL
enhanced	NULL
tyrosine	NULL
auto/transphosphoryla-tion	NULL
of	NULL
JAK3	NULL
within	NULL
minutes	NULL
after	NULL
crosslinking	NULL
of	NULL
a	NULL
conditional	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
chimera	NULL
and	NULL
is	NULL
a	NULL
prerequisite	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
transcription	NULL
factors	NULL
.	NULL

These	NULL
results	NULL
reveal	NULL
a	NULL
novel	NULL
activating	NULL
region	NULL
in	NULL
the	NULL
LMP1	NULL
C-terminus	NULL
and	NULL
identify	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
as	NULL
a	NULL
target	NULL
of	NULL
this	NULL
viral	NULL
integral	NULL
membrane	NULL
protein	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Keywords	NULL
:	NULL
B	NULL
lymphocyte/EBV/JAK3/LMP1/	NULL
STAT	NULL
protein	NULL
Introduction	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
is	NULL
a	NULL
widespread	NULL
human	NULL
y	NULL
herpes	NULL
virus	NULL
,	NULL
which	NULL
is	NULL
associated	NULL
with	NULL
several	NULL
human	NULL
malignancies	NULL
such	NULL
as	NULL
infectious	NULL
mononucleosis	NULL
,	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
,	NULL
nasopharyngeal	NULL
carcinoma	NULL
and	NULL
Hodgkin	NULL
's	NULL
disease	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Farrell	NULL
,	NULL
1995	NULL
;	NULL
Kieff	NULL
,	NULL
1996	NULL
)	NULL
.	NULL

The	NULL
infection	NULL
of	NULL
primary	NULL
B	NULL
cells	NULL
with	NULL
EBV	NULL
in	NULL
vitro	NULL
leads	NULL
to	NULL
the	NULL
immortalization	NULL
of	NULL
these	NULL
cells	NULL
generating	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
with	NULL
indefinite	NULL
life	NULL
span	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Farrell	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

Nine	NULL
viral	NULL
proteins	NULL
are	NULL
expressed	NULL
in	NULL
established	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
,	NULL
five	NULL
of	NULL
which	NULL
appear	NULL
to	NULL
be	NULL
absolutely	NULL
required	NULL
for	NULL
B	NULL
cell	NULL
immortalization	NULL
:	NULL
EBNA1I	NULL
,	NULL
2	NULL
,	NULL
3a	NULL
,	NULL
3¢c	NULL
and	NULL
LMP1	NULL
(	NULL
Hammerschmidt	NULL
and	NULL
3064	NULL
Sugden	NULL
,	NULL
1989	NULL
;	NULL
Cohen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Tomkinson	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
is	NULL
the	NULL
only	NULL
EBV	NULL
protein	NULL
which	NULL
has	NULL
a	NULL
transforming	NULL
potential	NULL
in	NULL
established	NULL
rodent	NULL
cell	NULL
lines	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
;	NULL
Baichwal	NULL
and	NULL
Sugden	NULL
,	NULL
1988	NULL
;	NULL
Moorthy	NULL
and	NULL
Thorley-Lawson	NULL
,	NULL
1993	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
LMP	NULL
1	NULL
induces	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
B	NULL
cell	NULL
activation	NULL
markers	NULL
CD23	NULL
and	NULL
CD40	NULL
,	NULL
cell	NULL
adhesion	NULL
molecules	NULL
ICAM1	NULL
,	NULL
LAF1	NULL
and	NULL
LFA3	NULL
(	NULL
Wang	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
)	NULL
,	NULL
and	NULL
the	NULL
epithelial	NULL
growth	NULL
factor	NULL
receptor	NULL
(	NULL
Miller	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

LMP1	NULL
is	NULL
composed	NULL
of	NULL
a	NULL
short	NULL
cytoplasmic	NULL
N-terminus	NULL
of	NULL
25	NULL
amino	NULL
acids	NULL
,	NULL
a	NULL
transmembrane	NULL
domain	NULL
with	NULL
six	NULL
membrane-spanning	NULL
segments	NULL
,	NULL
and	NULL
a	NULL
long	NULL
cytoplasmic	NULL
C-terminus	NULL
of	NULL
200	NULL
amino	NULL
acids	NULL
(	NULL
Liebowitz	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1986	NULL
)	NULL
.	NULL

Molecular	NULL
analysis	NULL
identified	NULL
two	NULL
cellular	NULL
signaling	NULL
pathways	NULL
targeted	NULL
by	NULL
LMP1	NULL
and	NULL
demonstrated	NULL
that	NULL
it	NULL
shares	NULL
functional	NULL
characteristics	NULL
with	NULL
members	NULL
of	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
receptor	NULL
superfamily	NULL
,	NULL
with	NULL
CD40	NULL
in	NULL
particular	NULL
(	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

LMP1	NULL
patches	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
via	NULL
its	NULL
transmembrane	NULL
domain	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Signal	NULL
transduction	NULL
is	NULL
mediated	NULL
by	NULL
the	NULL
C-terminus	NULL
which	NULL
interacts	NULL
with	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
receptor-associated	NULL
factors	NULL
(	NULL
TRAF	NULL
)	NULL
family	NULL
(	NULL
Mosialos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
and	NULL
with	NULL
the	NULL
TNF	NULL
receptor-associated	NULL
death	NULL
domain	NULL
protein	NULL
TRADD	NULL
(	NULL
Izumi	NULL
and	NULL
Kieff	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

These	NULL
are	NULL
features	NULL
reminiscent	NULL
of	NULL
TNF	NULL
receptors	NULL
although	NULL
differences	NULL
between	NULL
LMP1	NULL
and	NULL
TNF	NULL
receptors	NULL
in	NULL
the	NULL
architecture	NULL
of	NULL
signaling	NULL
complexes	NULL
and	NULL
mechanisms	NULL
emerge	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factors	NULL
NF-KB	NULL
(	NULL
Hammarskjold	NULL
and	NULL
Simurda	NULL
,	NULL
1992	NULL
;	NULL
Laherty	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
;	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Eliopoulos	NULL
and	NULL
Young	NULL
,	NULL
1998	NULL
)	NULL
may	NULL
account	NULL
for	NULL
many	NULL
of	NULL
the	NULL
cellular	NULL
changes	NULL
observed	NULL
in	NULL
response	NULL
to	NULL
LMP1	NULL
.	NULL

The	NULL
patched	NULL
phenotype	NULL
,	NULL
as	NULL
well	NULL
as	NULL
the	NULL
binding	NULL
of	NULL
molecules	NULL
involved	NULL
in	NULL
signal	NULL
transduction	NULL
cascades	NULL
,	NULL
are	NULL
characteristics	NULL
reminiscent	NULL
of	NULL
receptor	NULL
molecules	NULL
.	NULL

Unlike	NULL
other	NULL
receptors	NULL
,	NULL
whose	NULL
activation	NULL
depends	NULL
upon	NULL
ligand-binding	NULL
,	NULL
LMP1	NULL
is	NULL
constitutively	NULL
active	NULL
without	NULL
the	NULL
need	NULL
for	NULL
a	NULL
ligand	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Eliopoulos	NULL
and	NULL
Rickinson	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

Studies	NULL
using	NULL
cellular	NULL
systems	NULL
and	NULL
biochemical	NULL
approaches	NULL
clearly	NULL
demonstrated	NULL
that	NULL
the	NULL
membrane	NULL
localization	NULL
and	NULL
the	NULL
aggregation	NULL
of	NULL
the	NULL
cytoplasmic	NULL
C-terminus	NULL
of	NULL
LMP1	NULL
are	NULL
necessary	NULL
and	NULL
sufficient	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
signaling	NULL
events	NULL
in	NULL
epithelial	NULL
and	NULL
lymphoid	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
LMP1	NULL
's	NULL
N-terminus/transmembrane	NULL
domain	NULL
has	NULL
the	NULL
intrinsic	NULL
capacity	NULL
to	NULL
form	NULL
homoaggregates	NULL
in	NULL
the	NULL
plasma	NULL
membrane	NULL
which	NULL
results	NULL
in	NULL
a	NULL
constitutively	NULL
active	NULL
pseudo-receptor	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Eliopoulos	NULL
and	NULL
Rickinson	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
we	NULL
investigated	NULL
the	NULL
potential	NULL
of	NULL
LMP1	NULL
to	NULL
induce	NULL
other	NULL
cellular	NULL
signaling	NULL
cascades	NULL
besides	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
.	NULL

Since	NULL
LMP1	NULL
encompasses	NULL
a	NULL
long	NULL
(	NULL
200	NULL
amino	NULL
acids	NULL
)	NULL
cytoplasmic	NULL
signaling	NULL
domain	NULL
,	NULL
it	NULL
was	NULL
tempting	NULL
to	NULL
speculate	NULL
that	NULL
additional	NULL
pathways	NULL
are	NULL
©	NULL
European	NULL
Molecular	NULL
Biology	NULL
Organization	NULL
induced	NULL
by	NULL
LMP1	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
LMP1	NULL
triggers	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
,	NULL
which	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
activated	NULL
by	NULL
almost	NULL
all	NULL
known	NULL
cytokines	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Briscoe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
,	NULL
growth	NULL
factors	NULL
,	NULL
and	NULL
also	NULL
by	NULL
CD40	NULL
(	NULL
Hanissian	NULL
and	NULL
Geha	NULL
,	NULL
1997	NULL
;	NULL
Karras	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

The	NULL
JAK/STAT	NULL
signaling	NULL
cascade	NULL
involves	NULL
members	NULL
of	NULL
the	NULL
Janus	NULL
kinase	NULL
(	NULL
JAK	NULL
)	NULL
family	NULL
of	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
(	NULL
PTK	NULL
)	NULL
,	NULL
which	NULL
are	NULL
constitutively	NULL
bound	NULL
to	NULL
the	NULL
receptors	NULL
mentioned	NULL
above	NULL
.	NULL

Ligand-induced	NULL
aggregation	NULL
of	NULL
receptor	NULL
molecules	NULL
leads	NULL
to	NULL
the	NULL
autophosphorylation	NULL
of	NULL
JAKs	NULL
and	NULL
subsequently	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
(	NULL
signal	NULL
transducers	NULL
and	NULL
activators	NULL
of	NULL
transcription	NULL
)	NULL
proteins	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
STAT	NULL
proteins	NULL
dimerize	NULL
via	NULL
their	NULL
respective	NULL
SH2	NULL
domains	NULL
and	NULL
subsequently	NULL
translocate	NULL
into	NULL
the	NULL
nucleus	NULL
where	NULL
they	NULL
bind	NULL
to	NULL
specific	NULL
DNA	NULL
motifs	NULL
to	NULL
induce	NULL
gene	NULL
transcription	NULL
(	NULL
for	NULL
review	NULL
see	NULL
Briscoe	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

We	NULL
show	NULL
here	NULL
that	NULL
endogenous	NULL
LMP1	NULL
and	NULL
Janus	NULL
kinase	NULL
3	NULL
(	NULL
JAK3	NULL
)	NULL
interact	NULL
in	NULL
the	NULL
EBV-immortalized	NULL
B	NULL
cell	NULL
line	NULL
1852.4	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
as	NULL
well	NULL
as	NULL
in	NULL
293	NULL
cells	NULL
following	NULL
ectopic	NULL
expression	NULL
.	NULL

This	NULL
interaction	NULL
leads	NULL
to	NULL
an	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
which	NULL
requires	NULL
a	NULL
proline	NULL
rich	NULL
motif	NULL
and	NULL
surrounding	NULL
sequences	NULL
within	NULL
LMPI	NULL
's	NULL
33	NULL
bp	NULL
repeat	NULL
region	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
occurs	NULL
within	NULL
minutes	NULL
after	NULL
activation	NULL
of	NULL
the	NULL
chimeric	NULL
NGF-R	NULL
:	NULL
LMPI1	NULL
receptor	NULL
which	NULL
is	NULL
a	NULL
time	NULL
course	NULL
reminiscent	NULL
of	NULL
cytokine	NULL
receptors	NULL
.	NULL

Concomitantly	NULL
,	NULL
the	NULL
expression	NULL
of	NULL
LMP1	NULL
leads	NULL
to	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
.	NULL

Thus	NULL
,	NULL
LMPI1	NULL
is	NULL
revealed	NULL
to	NULL
be	NULL
a	NULL
pseudo-receptor	NULL
which	NULL
induces	NULL
multiple	NULL
and	NULL
distinct	NULL
signaling	NULL
pathways	NULL
.	NULL

The	NULL
simultaneous	NULL
or	NULL
sequential	NULL
activation	NULL
of	NULL
pathways	NULL
involved	NULL
in	NULL
cell	NULL
proliferation	NULL
or	NULL
protection	NULL
from	NULL
apoptosis	NULL
is	NULL
very	NULL
likely	NULL
to	NULL
be	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
function	NULL
of	NULL
LMP1	NULL
during	NULL
B	NULL
cell	NULL
immortalization	NULL
and	NULL
tumor	NULL
formation	NULL
.	NULL

Results	NULL
The	NULL
C-terminus	NULL
of	NULL
LMP1	NULL
contains	NULL
JAK	NULL
interaction	NULL
motifs	NULL
So	NULL
far	NULL
,	NULL
two	NULL
C-terminal	NULL
activating	NULL
regions	NULL
(	NULL
CTAR1	NULL
and	NULL
2	NULL
)	NULL
in	NULL
the	NULL
cytoplasmic	NULL
domain	NULL
of	NULL
LMP1	NULL
have	NULL
been	NULL
described	NULL
.	NULL

They	NULL
are	NULL
located	NULL
in	NULL
the	NULL
proximity	NULL
of	NULL
the	NULL
transmembrane	NULL
domain	NULL
and	NULL
the	NULL
distal	NULL
C-terminus	NULL
,	NULL
respectively	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
(	NULL
Huen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Both	NULL
CTAR1	NULL
and	NULL
2	NULL
are	NULL
necessary	NULL
for	NULL
full	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
efficient	NULL
B	NULL
cell	NULL
immortalization	NULL
(	NULL
Kaye	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Devergne	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Izumi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
;	NULL
whereas	NULL
CTAR2	NULL
appears	NULL
to	NULL
be	NULL
the	NULL
sole	NULL
mediator	NULL
of	NULL
JNK-1	NULL
and	NULL
AP-1	NULL
activation	NULL
by	NULL
LMP1	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
,	NULL
1999	NULL
;	NULL
Eliopoulos	NULL
and	NULL
Young	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

In	NULL
order	NULL
to	NULL
identify	NULL
additional	NULL
potential	NULL
signaling	NULL
mediators	NULL
engaged	NULL
by	NULL
LMP1	NULL
,	NULL
we	NULL
screened	NULL
its	NULL
C-terminus	NULL
for	NULL
consensus	NULL
sequences	NULL
which	NULL
might	NULL
be	NULL
important	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
signal	NULL
transducers	NULL
.	NULL

Besides	NULL
the	NULL
already	NULL
known	NULL
PXQXT/S	NULL
motifs	NULL
for	NULL
TRAF	NULL
binding	NULL
(	NULL
within	NULL
CTAR1	NULL
)	NULL
and	NULL
the	NULL
YYD	NULL
motif	NULL
for	NULL
TRADD	NULL
binding	NULL
(	NULL
within	NULL
CTAR2	NULL
)	NULL
,	NULL
LMP1	NULL
has	NULL
additional	NULL
consensus	NULL
sites	NULL
which	NULL
are	NULL
characteristic	NULL
for	NULL
the	NULL
interaction	NULL
with	NULL
members	NULL
of	NULL
the	NULL
JAK	NULL
family	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
(	NULL
Murakami	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1991	NULL
;	NULL
Thle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

These	NULL
consensus	NULL
sites	NULL
are	NULL
classified	NULL
as	NULL
box	NULL
1	NULL
motif	NULL
,	NULL
which	NULL
is	NULL
a	NULL
proline-rich	NULL
sequence	NULL
(	NULL
PXXPXP	NULL
)	NULL
believed	NULL
to	NULL
serve	NULL
as	NULL
a	NULL
docking	NULL
site	NULL
for	NULL
JAKs	NULL
and	NULL
as	NULL
box	NULL
2	NULL
motif	NULL
which	NULL
may	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
kinase	NULL
activation	NULL
although	NULL
its	NULL
exact	NULL
role	NULL
is	NULL
less	NULL
well	NULL
documented	NULL
(	NULL
Ihle	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Ivashkiv	NULL
,	NULL
1995	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
1	NULL
,	NULL
the	NULL
C-terminus	NULL
of	NULL
LMP1	NULL
activates	NULL
JAK/STAT	NULL
LMP1	NULL
JAK	NULL
consensus	NULL
sequences	NULL
a2386	NULL
aa185	NULL
TRAF	NULL
YHGQRHSDEHHHDDSLPHPQQATDDSGHES	NULL
DSNNEGRHHLLVSGAGDGPPLCSQNLGAPG	NULL
M	NULL
M	NULL
M	NULL
GGPDNGPQDPDNTDDNGPQDPDNTDDNG	NULL
box	NULL
1	NULL
v	NULL
v	NULL
box	NULL
1	NULL
_	NULL
y	NULL
PHDPLPQDPDNTDDNGPQDPDNTDDNGPHDPLP	NULL
box	NULL
2	NULL
HSPSDSAGNDGGPPQLTEEVENKIGGDQGPP	NULL
LMTDGGGGHSHDSGHGGGDPHLPTLLLGSS	NULL
TRADD	NULL
GSGGDDDDPHGPVQLSYYD	NULL
9	NULL
an38	NULL
Fig	NULL
.	NULL

1	NULL
.	NULL

Consensus	NULL
sequence	NULL
motifs	NULL
for	NULL
JAK	NULL
binding	NULL
within	NULL
the	NULL
C-terminus	NULL
of	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
.	NULL

Top	NULL
:	NULL
schematic	NULL
representation	NULL
of	NULL
the	NULL
LMP1	NULL
protein	NULL
of	NULL
the	NULL
EBV	NULL
strain	NULL
B95.8	NULL
with	NULL
consensus	NULL
binding	NULL
sequences	NULL
.	NULL

Shown	NULL
are	NULL
the	NULL
two	NULL
C-terminal	NULL
activating	NULL
regions	NULL
1	NULL
and	NULL
2	NULL
(	NULL
CTAR1/2	NULL
;	NULL
filled	NULL
rectangles	NULL
)	NULL
and	NULL
box	NULL
1	NULL
and	NULL
box	NULL
2	NULL
motifs	NULL
(	NULL
open	NULL
rectangles	NULL
)	NULL
.	NULL

Bottom	NULL
:	NULL
the	NULL
amino	NULL
acid	NULL
sequence	NULL
of	NULL
the	NULL
cytoplasmic	NULL
C-terminus	NULL
of	NULL
LMP1	NULL
(	NULL
aa	NULL
185-386	NULL
)	NULL
is	NULL
depicted	NULL
with	NULL
the	NULL
consensus	NULL
binding	NULL
sequences	NULL
for	NULL
JAK	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Two	NULL
identical	NULL
box	NULL
1	NULL
motifs	NULL
(	NULL
PXXPXP	NULL
)	NULL
are	NULL
located	NULL
at	NULL
amino	NULL
acid	NULL
positions	NULL
275-280	NULL
and	NULL
302-307	NULL
.	NULL

The	NULL
single	NULL
box	NULL
2	NULL
motif	NULL
(	NULL
PPQLTEEVENK	NULL
)	NULL
is	NULL
located	NULL
at	NULL
amino	NULL
acid	NULL
position	NULL
320-330	NULL
and	NULL
precedes	NULL
the	NULL
last	NULL
55	NULL
amino	NULL
acids	NULL
,	NULL
which	NULL
are	NULL
important	NULL
for	NULL
TRADD	NULL
binding	NULL
and	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
activation	NULL
.	NULL

The	NULL
two	NULL
box	NULL
1	NULL
motifs	NULL
are	NULL
located	NULL
within	NULL
the	NULL
heterogeneous	NULL
stretch	NULL
of	NULL
33	NULL
bp	NULL
repeats	NULL
whereas	NULL
the	NULL
box	NULL
2	NULL
motif	NULL
localizes	NULL
to	NULL
a	NULL
non-repetitive	NULL
segment	NULL
further	NULL
downstream	NULL
.	NULL

LMP1	NULL
of	NULL
the	NULL
B95.8	NULL
strain	NULL
has	NULL
four	NULL
and	NULL
a	NULL
half	NULL
repetitive	NULL
sequence	NULL
units	NULL
as	NULL
indicated	NULL
by	NULL
arrowheads	NULL
.	NULL

The	NULL
repetitive	NULL
elements	NULL
consist	NULL
of	NULL
three	NULL
perfect	NULL
copies	NULL
of	NULL
a	NULL
simple	NULL
33	NULL
bp	NULL
motif	NULL
,	NULL
one	NULL
extended	NULL
version	NULL
with	NULL
a	NULL
single	NULL
box	NULL
1	NULL
consensus	NULL
sequence	NULL
,	NULL
and	NULL
a	NULL
truncated	NULL
repeat	NULL
also	NULL
encoding	NULL
a	NULL
box	NULL
1	NULL
motif	NULL
.	NULL

LMP1	NULL
contains	NULL
two	NULL
identical	NULL
box	NULL
1	NULL
motifs	NULL
(	NULL
PHDPLP	NULL
,	NULL
amino	NULL
acids	NULL
275-280	NULL
and	NULL
302-307	NULL
)	NULL
as	NULL
well	NULL
as	NULL
one	NULL
box	NULL
2	NULL
motif	NULL
(	NULL
PPQLTEEVENK	NULL
,	NULL
amino	NULL
acids	NULL
320-330	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LMP	NULL
1	NULL
might	NULL
interact	NULL
with	NULL
PTKs	NULL
of	NULL
the	NULL
JAK	NULL
family	NULL
leading	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
box	NULL
1	NULL
consensus	NULL
motifs	NULL
are	NULL
located	NULL
within	NULL
a	NULL
highly	NULL
repetitive	NULL
region	NULL
of	NULL
LMP1	NULL
termed	NULL
'33	NULL
base	NULL
pair	NULL
repeats	NULL
'	NULL
whose	NULL
function	NULL
is	NULL
unknown	NULL
so	NULL
far	NULL
.	NULL

LMP1	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
activates	NULL
the	NULL
STAT	NULL
proteins	NULL
The	NULL
consensus	NULL
motif	NULL
search	NULL
prompted	NULL
us	NULL
to	NULL
investigate	NULL
the	NULL
activation	NULL
status	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
in	NULL
conjunction	NULL
with	NULL
LMP1	NULL
expression	NULL
.	NULL

Primary	NULL
B	NULL
lymphocytes	NULL
which	NULL
had	NULL
been	NULL
immortalized	NULL
with	NULL
a	NULL
mini-EBV	NULL
plasmid	NULL
carrying	NULL
a	NULL
conditional	NULL
LMP1	NULL
allele	NULL
were	NULL
used	NULL
for	NULL
this	NULL
purpose	NULL
.	NULL

The	NULL
LMP1	NULL
gene	NULL
is	NULL
under	NULL
control	NULL
of	NULL
a	NULL
tetracycline-dependent	NULL
promoter	NULL
and	NULL
withdrawal	NULL
of	NULL
tetracycline	NULL
leads	NULL
to	NULL
the	NULL
transcriptional	NULL
downregulation	NULL
of	NULL
the	NULL
LMP1	NULL
gene	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

To	NULL
minimize	NULL
LMP1	NULL
expression	NULL
initially	NULL
,	NULL
the	NULL
1852.4	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
the	NULL
3065	NULL
O.Gires	NULL
et	NULL
al	NULL
.	NULL

absence	NULL
of	NULL
tetracycline	NULL
for	NULL
4	NULL
days	NULL
.	NULL

Subsequently	NULL
,	NULL
LMP1	NULL
was	NULL
reinduced	NULL
by	NULL
adding	NULL
tetracycline	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
from	NULL
day	NULL
1	NULL
to	NULL
4	NULL
with	NULL
the	NULL
intention	NULL
to	NULL
boost	NULL
and	NULL
synchronize	NULL
LMP1	NULL
re-expression	NULL
.	NULL

The	NULL
controls	NULL
were	NULL
kept	NULL
under	NULL
identical	NULL
conditions	NULL
except	NULL
that	NULL
they	NULL
did	NULL
not	NULL
receive	NULL
tetracycline	NULL
.	NULL

Simultaneous	NULL
activation	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
was	NULL
assessed	NULL
in	NULL
cell	NULL
lysates	NULL
by	NULL
performing	NULL
a	NULL
gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
(	NULL
GEMSA	NULL
)	NULL
using	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
STAT1	NULL
and	NULL
3	NULL
.	NULL

As	NULL
a	NULL
control	NULL
the	NULL
human	NULL
embryonic	NULL
kidney	NULL
cell	NULL
line	NULL
293	NULL
was	NULL
treated	NULL
with	NULL
IFNy	NULL
for	NULL
15	NULL
min	NULL
(	NULL
Figure	NULL
2A	NULL
,	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

In	NULL
human	NULL
cells	NULL
,	NULL
IFNy	NULL
strongly	NULL
induces	NULL
STAT1	NULL
which	NULL
leads	NULL
to	NULL
the	NULL
formation	NULL
of	NULL
STAT	NULL
Reinduction	NULL
of	NULL
LMP1	NULL
in	NULL
1852.4-immortalized	NULL
B	NULL
lymphocytes	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
complex	NULL
similar	NULL
in	NULL
size	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
IFNy-treated	NULL
293	NULL
cells	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

The	NULL
DNA-binding	NULL
activity	NULL
of	NULL
STATs	NULL
peaked	NULL
at	NULL
day	NULL
1	NULL
after	NULL
tetracycline	NULL
readdition	NULL
and	NULL
declined	NULL
over	NULL
the	NULL
following	NULL
3	NULL
days	NULL
,	NULL
but	NULL
was	NULL
still	NULL
substantial	NULL
at	NULL
day	NULL
4	NULL
after	NULL
tetracycline	NULL
readdition	NULL
(	NULL
Figure	NULL
2A	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
a-STAT1	NULL
antibody	NULL
led	NULL
to	NULL
the	NULL
disruption	NULL
of	NULL
the	NULL
observed	NULL
complex	NULL
,	NULL
while	NULL
G-JAK3	NULL
antibody	NULL
as	NULL
a	NULL
control	NULL
antibody	NULL
had	NULL
no	NULL
effect	NULL
.	NULL

The	NULL
readdition	NULL
of	NULL
tetracycline	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
of	NULL
1852.4	NULL
cells	NULL
induced	NULL
the	NULL
expression	NULL
of	NULL
LMP1	NULL
(	NULL
Figure	NULL
2B	NULL
)	NULL
as	NULL
expected	NULL
without	NULL
affecting	NULL
the	NULL
expression	NULL
levels	NULL
of	NULL
STAT1	NULL
(	NULL
Figure	NULL
2C	NULL
)	NULL
.	NULL

These	NULL
results	NULL
show	NULL
that	NULL
LMP1	NULL
induces	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
at	NULL
least	NULL
STAT1	NULL
to	NULL
specific	NULL
DNA	NULL
sequences	NULL
suggesting	NULL
that	NULL
LMP1	NULL
engages	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
in	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
.	NULL

Activation	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
is	NULL
a	NULL
rapid	NULL
process	NULL
involving	NULL
JAK3	NULL
The	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
the	NULL
1852.4	NULL
cell	NULL
line	NULL
could	NULL
result	NULL
either	NULL
from	NULL
autocrine	NULL
loops	NULL
in	NULL
which	NULL
LMP1	NULL
induced	NULL
the	NULL
release	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
IL-6	NULL
(	NULL
Tosato	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Eliopoulos	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
or	NULL
from	NULL
a	NULL
direct	NULL
activation	NULL
following	NULL
LMP1	NULL
re-expression	NULL
.	NULL

To	NULL
distinguish	NULL
between	NULL
these	NULL
possibilities	NULL
a	NULL
conditional	NULL
LMP1	NULL
molecule	NULL
was	NULL
used	NULL
which	NULL
can	NULL
be	NULL
activated	NULL
at	NULL
will	NULL
within	NULL
minutes	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

This	NULL
LMP1	NULL
molecule	NULL
is	NULL
a	NULL
chimera	NULL
between	NULL
the	NULL
low	NULL
affinity	NULL
nerve	NULL
growth	NULL
receptor	NULL
(	NULL
NGF-R	NULL
)	NULL
and	NULL
the	NULL
C-terminal	NULL
signaling	NULL
domain	NULL
of	NULL
LMP1	NULL
.	NULL

The	NULL
chimeric	NULL
receptor	NULL
localizes	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
where	NULL
it	NULL
can	NULL
be	NULL
aggregated	NULL
by	NULL
an	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
extracellular	NULL
part	NULL
of	NULL
the	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
molecule	NULL
,	NULL
thereby	NULL
mimicking	NULL
receptor	NULL
activation	NULL
(	NULL
Gires	NULL
ef	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
encoding	NULL
wild-type	NULL
LMP	NULL
or	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
molecules	NULL
were	NULL
cross-linked	NULL
for	NULL
15	NULL
and	NULL
45	NULL
min	NULL
using	NULL
a	NULL
murine	NULL
G-NGF-R	NULL
antibody	NULL
in	NULL
combination	NULL
with	NULL
an	NULL
a-mouse	NULL
immunoglobulin	NULL
secondary	NULL
antibody	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
subjected	NULL
to	NULL
GEMSA	NULL
using	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
STAT1/3	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Surprisingly	NULL
,	NULL
no	NULL
specific	NULL
band	NULL
shift	NULL
could	NULL
be	NULL
observed	NULL
in	NULL
either	NULL
of	NULL
the	NULL
single	NULL
transfectants	NULL
,	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
3A	NULL
.	NULL

We	NULL
reasoned	NULL
that	NULL
one	NULL
or	NULL
more	NULL
components	NULL
involved	NULL
in	NULL
the	NULL
JAK/STAT	NULL
signaling	NULL
pathway	NULL
might	NULL
be	NULL
missing	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

Since	NULL
JAK3	NULL
is	NULL
lymphocyte	NULL
specific	NULL
(	NULL
Tortolani	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
it	NULL
was	NULL
the	NULL
prime	NULL
candidate	NULL
for	NULL
complementation	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

Additionally	NULL
,	NULL
JAK3	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
constitutively	NULL
activated	NULL
in	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
in	NULL
HTLV-immortalized	NULL
T	NULL
cells	NULL
(	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Weber-Nordt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Murata	NULL
and	NULL
Puri	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
JAK3	NULL
was	NULL
co-transfected	NULL
3066	NULL
A	NULL
c-JAK3	NULL
IFNy	NULL
Tet	NULL
:	NULL
-	NULL
ra	NULL
za	NULL
3d	NULL
44	NULL
1d	NULL
24	NULL
3d	NULL
44	NULL
1d	NULL
24	NULL
34	NULL
4d	NULL
|	NULL
-	NULL
ad	NULL
-~	NULL
+	NULL
r	NULL
i	NULL
’	NULL
uciinomnn-onné	NULL
c	NULL
]	NULL
B	NULL
a	NULL
detection	NULL
l.	NULL
de	NULL
_	NULL
e	NULL
__	NULL
c-LMP1	NULL
-=	NULL
-Tet	NULL
1d	NULL
2d	NULL
4d	NULL
E	NULL
5	NULL
aG	NULL
HE	NULL
=-	NULL
S	NULL
+Tet	NULL
C	NULL
detection	NULL
cx-STAT1	NULL
an	NULL
on	NULL
an	NULL
on	NULL
&	NULL
-Tet	NULL
1d	NULL
2d	NULL
3d	NULL
_	NULL
4d	NULL
e	NULL
+Tet	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

Activation	NULL
of	NULL
STAT	NULL
proteins	NULL
following	NULL
the	NULL
expression	NULL
of	NULL
LMP1	NULL
in	NULL
the	NULL
1852.4-immortalized	NULL
B	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
1852.4	NULL
cells	NULL
are	NULL
immortalized	NULL
human	NULL
B	NULL
cells	NULL
carrying	NULL
a	NULL
conditional	NULL
,	NULL
tetracycline-regulated	NULL
LMP1	NULL
gene	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
mini-EBV	NULL
plasmid	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

1852.4	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
for	NULL
four	NULL
days	NULL
(	NULL
Tet	NULL
)	NULL
which	NULL
leads	NULL
to	NULL
transcriptional	NULL
downregulation	NULL
of	NULL
the	NULL
LMP1	NULL
gene	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
LMP1	NULL
was	NULL
reinduced	NULL
upon	NULL
readdition	NULL
of	NULL
tetracycline	NULL
for	NULL
four	NULL
days	NULL
(	NULL
Tet	NULL
1d	NULL
,	NULL
2d	NULL
,	NULL
3d	NULL
or	NULL
4d	NULL
)	NULL
and	NULL
cell	NULL
extracts	NULL
prepared	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
293	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
15	NULL
min	NULL
with	NULL
recombinant	NULL
IFNy	NULL
and	NULL
the	NULL
cells	NULL
lysed	NULL
under	NULL
the	NULL
same	NULL
conditions	NULL
.	NULL

GEMSAs	NULL
were	NULL
performed	NULL
using	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
STAT1	NULL
and	NULL
STAT3	NULL
proteins	NULL
.	NULL

Where	NULL
indicated	NULL
antibodies	NULL
specific	NULL
for	NULL
JAK3	NULL
(	NULL
@	NULL
-JAK3	NULL
)	NULL
or	NULL
STAT1	NULL
(	NULL
@	NULL
-STAT1	NULL
)	NULL
were	NULL
incubated	NULL
with	NULL
the	NULL
extracts	NULL
.	NULL

The	NULL
STAT-specific	NULL
complex	NULL
is	NULL
indicated	NULL
by	NULL
an	NULL
arrow	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Expression	NULL
levels	NULL
of	NULL
LMP1	NULL
as	NULL
a	NULL
function	NULL
of	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
tetracycline	NULL
were	NULL
assessed	NULL
.	NULL

Proteins	NULL
were	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
LMP1	NULL
was	NULL
detected	NULL
using	NULL
the	NULL
CS1-4	NULL
antibody	NULL
mix	NULL
in	NULL
combination	NULL
with	NULL
a	NULL
HRP-conjugated	NULL
secondary	NULL
antibody	NULL
.	NULL

The	NULL
LMP1	NULL
control	NULL
lane	NULL
contains	NULL
the	NULL
crude	NULL
extract	NULL
of	NULL
293	NULL
cells	NULL
transiently	NULL
transfected	NULL
with	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
wild-type	NULL
LMP1	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Expression	NULL
levels	NULL
of	NULL
immunoprecipitated	NULL
STAT1	NULL
was	NULL
assessed	NULL
as	NULL
a	NULL
function	NULL
of	NULL
LMP1	NULL
re-expression	NULL
.	NULL

Proteins	NULL
were	NULL
immunoprecipitated	NULL
from	NULL
1852.4	NULL
B	NULL
cell	NULL
lysates	NULL
using	NULL
an	NULL
@	NULL
-STAT1	NULL
antibody	NULL
and	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
.	NULL

STAT1	NULL
levels	NULL
were	NULL
detected	NULL
with	NULL
specific	NULL
antibodies	NULL
and	NULL
show	NULL
a	NULL
double	NULL
band	NULL
of	NULL
91	NULL
and	NULL
84	NULL
kDa	NULL
as	NULL
expected	NULL
.	NULL

together	NULL
with	NULL
expression	NULL
plasmids	NULL
encoding	NULL
LMPI1	NULL
or	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
in	NULL
the	NULL
next	NULL
set	NULL
of	NULL
experiments	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
molecules	NULL
were	NULL
cross-linked	NULL
and	NULL
cell	NULL
lysates	NULL
were	NULL
analyzed	NULL
as	NULL
described	NULL
above	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
a	NULL
band	NULL
shift	NULL
comparable	NULL
to	NULL
that	NULL
observed	NULL
in	NULL
the	NULL
1852.4	NULL
B	NULL
cell	NULL
line	NULL
was	NULL
clearly	NULL
dependent	NULL
upon	NULL
cross-linking	NULL
of	NULL
NGF-	NULL
A	NULL
cross-linking	NULL
:	NULL
-	NULL
=	NULL
-_	NULL
+	NULL
+	NULL
In	NULL
L.	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
mock	NULL
LMP1	NULL
NGF-R	NULL
:	NULL
LMPL	NULL
|	NULL
‘	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
.	NULL

mock	NULL
LMP1	NULL
activates	NULL
JAK/STAT	NULL
&	NULL
&	NULL
&	NULL
-o	NULL
#	NULL
+	NULL
*	NULL
u	NULL
le	NULL
«	NULL
€	NULL
LMP1	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
NGE-R	NULL
:	NULL
LMP1T	NULL
NGE-R	NULL
:	NULL
LMP1	NULL
£	NULL
>	NULL
Z	NULL
tas	NULL
&	NULL
3	NULL
»	NULL
7	NULL
.	NULL

#	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

Rapid	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
by	NULL
LMP1	NULL
in	NULL
the	NULL
human	NULL
embryonic	NULL
kidney	NULL
cell	NULL
line	NULL
293	NULL
is	NULL
dependent	NULL
on	NULL
JAK3	NULL
.	NULL

Short-term	NULL
cross-linking	NULL
of	NULL
the	NULL
conditional	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
chimera	NULL
activates	NULL
STAT	NULL
proteins	NULL
in	NULL
293	NULL
cells	NULL
and	NULL
is	NULL
dependent	NULL
on	NULL
the	NULL
cotransfection	NULL
of	NULL
JAK3	NULL
.	NULL

(	NULL
A	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
LMP1	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
or	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
as	NULL
indicated	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
cross-linking	NULL
antibodies	NULL
(	NULL
murine	NULL
@	NULL
-NGF-R	NULL
in	NULL
combination	NULL
with	NULL
@	NULL
-mouse	NULL
immunoglobulin	NULL
antibody	NULL
as	NULL
indicated	NULL
by	NULL
'+	NULL
'	NULL
)	NULL
or	NULL
with	NULL
secondary	NULL
antibody	NULL
alone	NULL
Ig	NULL
as	NULL
indicated	NULL
by	NULL
*-*	NULL
)	NULL
for	NULL
the	NULL
time	NULL
period	NULL
indicated	NULL
.	NULL

Subsequently	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
GEMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
methods	NULL
using	NULL
a	NULL
probe	NULL
specific	NULL
for	NULL
STAT1	NULL
and	NULL
STAT3	NULL
proteins	NULL
.	NULL

(	NULL
B	NULL
)	NULL
As	NULL
in	NULL
(	NULL
A	NULL
)	NULL
,	NULL
with	NULL
additional	NULL
cotransfection	NULL
of	NULL
an	NULL
expression	NULL
plasmid	NULL
for	NULL
JAK3	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
.	NULL

The	NULL
shifted	NULL
complexes	NULL
specific	NULL
for	NULL
STAT1/3	NULL
are	NULL
indicated	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
C	NULL
)	NULL
As	NULL
in	NULL
(	NULL
B	NULL
)	NULL
,	NULL
with	NULL
untreated	NULL
or	NULL
cross-linked	NULL
NGE-R	NULL
:	NULL
LMP1	NULL
molecules	NULL
.	NULL

The	NULL
expected	NULL
size	NULL
of	NULL
the	NULL
STAT	NULL
complex	NULL
is	NULL
indicated	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

The	NULL
question	NULL
mark	NULL
indicates	NULL
an	NULL
unidentified	NULL
shift	NULL
complex	NULL
which	NULL
seems	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
LMP1	NULL
in	NULL
conjunction	NULL
with	NULL
JAK3	NULL
in	NULL
293	NULL
cells	NULL
only	NULL
,	NULL
as	NULL
described	NULL
in	NULL
the	NULL
Results	NULL
.	NULL

R	NULL
:	NULL
LMP1	NULL
and	NULL
co-expression	NULL
of	NULL
JAK3	NULL
.	NULL

Activation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
these	NULL
experiments	NULL
was	NULL
a	NULL
rapid	NULL
process	NULL
occurring	NULL
within	NULL
15	NULL
min	NULL
after	NULL
LMP1	NULL
cross-linking	NULL
,	NULL
while	NULL
the	NULL
shifted	NULL
complexes	NULL
were	NULL
still	NULL
present	NULL
with	NULL
lower	NULL
intensity	NULL
after	NULL
45	NULL
min	NULL
.	NULL

In	NULL
the	NULL
absence	NULL
of	NULL
primary	NULL
-NGF-R	NULL
antibody	NULL
no	NULL
significant	NULL
induction	NULL
of	NULL
STAT	NULL
DNA-binding	NULL
activity	NULL
was	NULL
observed	NULL
(	NULL
Figure	NULL
3C	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
LMP1	NULL
together	NULL
with	NULL
JAK3	NULL
induced	NULL
a	NULL
weak	NULL
band	NULL
shift	NULL
only	NULL
,	NULL
which	NULL
most	NULL
likely	NULL
reflects	NULL
the	NULL
steady-state	NULL
activation	NULL
level	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
by	NULL
constitutively	NULL
active	NULL
LMP1	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
JAK3	NULL
were	NULL
critical	NULL
in	NULL
these	NULL
experiments	NULL
since	NULL
overexpression	NULL
led	NULL
to	NULL
a	NULL
constitutive	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
which	NULL
is	NULL
expected	NULL
due	NULL
to	NULL
autophosphorylation	NULL
of	NULL
JAK3	NULL
at	NULL
high	NULL
expression	NULL
levels	NULL
(	NULL
Silvennoinen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
;	NULL
see	NULL
also	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMPI	NULL
we	NULL
consistently	NULL
observed	NULL
the	NULL
induction	NULL
of	NULL
a	NULL
lower	NULL
migrating	NULL
band	NULL
whose	NULL
nature	NULL
is	NULL
unknown	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

Autophosphorylation	NULL
of	NULL
JAK3	NULL
on	NULL
tyrosine	NULL
residues	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
ectopic	NULL
expression	NULL
of	NULL
LMP1	NULL
in	NULL
293	NULL
cells	NULL
Ligand	NULL
binding	NULL
by	NULL
cytokine	NULL
receptors	NULL
leads	NULL
to	NULL
an	NULL
increased	NULL
phosphorylation	NULL
of	NULL
JAK	NULL
proteins	NULL
on	NULL
tyrosine	NULL
residues	NULL
which	NULL
results	NULL
in	NULL
an	NULL
enhanced	NULL
kinase	NULL
activity	NULL
.	NULL

Since	NULL
JAK3	NULL
expression	NULL
was	NULL
mandatory	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
by	NULL
LMP1	NULL
as	NULL
shown	NULL
in	NULL
transient	NULL
transfection	NULL
experiments	NULL
in	NULL
293	NULL
cells	NULL
we	NULL
investigated	NULL
the	NULL
activation	NULL
status	NULL
of	NULL
JAK3	NULL
as	NULL
a	NULL
function	NULL
of	NULL
LMP1	NULL
expression	NULL
.	NULL

LMP1	NULL
and	NULL
murine	NULL
JAK3	NULL
expression	NULL
plasmids	NULL
were	NULL
transfected	NULL
in	NULL
293	NULL
cells	NULL
in	NULL
the	NULL
combinations	NULL
as	NULL
indicated	NULL
in	NULL
Figure	NULL
4A	NULL
.	NULL

Twenty	NULL
hours	NULL
post	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
phosphatase	NULL
and	NULL
protease	NULL
inhibitors	NULL
and	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
detected	NULL
using	NULL
antibodies	NULL
.	NULL

Transfection	NULL
of	NULL
JAK3	NULL
alone	NULL
resulted	NULL
in	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
tyrosine	NULL
phosphorylated	NULL
protein	NULL
of	NULL
~125	NULL
kDa	NULL
which	NULL
is	NULL
the	NULL
expected	NULL
molecular	NULL
weight	NULL
of	NULL
JAK3	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Cotransfection	NULL
of	NULL
LMP1	NULL
with	NULL
JAK3	NULL
strongly	NULL
increased	NULL
the	NULL
phosphorylation	NULL
of	NULL
this	NULL
protein	NULL
.	NULL

Immunoprecipitation	NULL
using	NULL
antibodies	NULL
directed	NULL
against	NULL
JAK3	NULL
and	NULL
subsequent	NULL
detection	NULL
of	NULL
phosphorylated	NULL
tyrosine	NULL
residues	NULL
clearly	NULL
identified	NULL
the	NULL
125	NULL
kDa	NULL
protein	NULL
as	NULL
JAK3	NULL
(	NULL
Figure	NULL
5B	NULL
,	NULL
right	NULL
panel	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
LMP1	NULL
was	NULL
analyzed	NULL
following	NULL
immunoprecipitation	NULL
and	NULL
was	NULL
found	NULL
to	NULL
be	NULL
similar	NULL
in	NULL
the	NULL
LMP1	NULL
transfectants	NULL
(	NULL
Figure	NULL
4A	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
cotransfected	NULL
a	NULL
kinase-defective	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
JAK3	NULL
(	NULL
Kawahara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
(	NULL
JAK3AKD	NULL
)	NULL
together	NULL
with	NULL
wild-type	NULL
LMP1	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4B	NULL
,	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
completely	NULL
blocked	NULL
by	NULL
JAK3AKD	NULL
,	NULL
demonstrating	NULL
that	NULL
JAK3	NULL
phosphorylation	NULL
was	NULL
the	NULL
result	NULL
of	NULL
auto/transphosphorylation	NULL
.	NULL

In	NULL
vitro	NULL
translation	NULL
of	NULL
JAK3AKD	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
protein	NULL
of	NULL
87	NULL
kDa	NULL
as	NULL
predicted	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
the	NULL
following	NULL
experiment	NULL
we	NULL
analyzed	NULL
the	NULL
kinetic	NULL
JAK3	NULL
phosphorylation	NULL
after	NULL
activation	NULL
of	NULL
LMP	NULL
1	NULL
signaling	NULL
.	NULL

LMP	NULL
1	NULL
,	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
and	NULL
JAK3	NULL
expression	NULL
plasmids	NULL
were	NULL
cotransfected	NULL
in	NULL
293	NULL
cells	NULL
in	NULL
combinations	NULL
as	NULL
indicated	NULL
in	NULL
Figure	NULL
4C	NULL
.	NULL

Twenty-four	NULL
hours	NULL
post	NULL
transfection	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
molecules	NULL
were	NULL
either	NULL
cross-linked	NULL
for	NULL
15	NULL
min	NULL
with	NULL
the	NULL
antibody	NULL
directed	NULL
against	NULL
the	NULL
external	NULL
NGF-R	NULL
part	NULL
in	NULL
conjunction	NULL
with	NULL
the	NULL
secondary	NULL
antibody	NULL
or	NULL
treated	NULL
with	NULL
secondary	NULL
antibody	NULL
only	NULL
.	NULL

Cells	NULL
were	NULL
lysed	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
assessed	NULL
by	NULL
Western	NULL
blotting	NULL
and	NULL
immunodetection	NULL
with	NULL
antibodies	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
4C	NULL
,	NULL
strong	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
3067	NULL
O.Gires	NULL
et	NULL
al	NULL
.	NULL

133kD	NULL
-	NULL
detection	NULL
intead	NULL
c-phosphotyrosine	NULL
cell	NULL
lysate	NULL
ceLMP	NULL
]	NULL
IP	NULL
.	NULL

c-LMPI	NULL
§	NULL
=	NULL
a	NULL
«	NULL
-	NULL
m	NULL
=s	NULL
«	NULL
4	NULL
3	NULL
detection	NULL
133kD	NULL
f	NULL
cell	NULL
lysate	NULL
c-phosphotyrosine	NULL
i	NULL
6D	NULL
-	NULL
``	NULL
--	NULL
pos	NULL
0m	NULL
ao	NULL
4	NULL
a	NULL
€	NULL
1	NULL
&	NULL
5	NULL
k	NULL
5	NULL
|	NULL
§	NULL
f	NULL
2	NULL
3	NULL
$	NULL
{	NULL
$	NULL
.	NULL

3	NULL
$	NULL
|	NULL
-=	NULL
&	NULL
i	NULL
<	NULL
0	NULL
4	NULL
``	NULL
&	NULL
3	NULL
cross-linking	NULL
:	NULL
_	NULL
un	NULL
_	NULL
un	NULL
__	NULL
-	NULL
+	NULL
un	NULL
_	NULL
un	NULL
_-	NULL
+	NULL
-	NULL
detection	NULL
133	NULL
kD	NULL
-	NULL
r	NULL
_	NULL
cell	NULL
lysate	NULL
Lazarus-5h	NULL
;	NULL
97kD	NULL
--	NULL
Pog	NULL
PoP	NULL
f	NULL
:	NULL
P	NULL
:	NULL
£5	NULL
$	NULL
%	NULL
f	NULL
i	NULL
j	NULL
§	NULL
¢	NULL
¢	NULL
$	NULL
&	NULL
Heo	NULL
K	NULL
&	NULL
0	NULL
w	NULL
&	NULL
&	NULL
9	NULL
Bel	NULL
Z	NULL
Z	NULL
Z	NULL
zZ	NULL
___	NULL
U	NULL
+JAK3	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Fast	NULL
tyrosine	NULL
autophosphorylation	NULL
of	NULL
JAK3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMP1	NULL
.	NULL

Tyrosine	NULL
autophosphorylation	NULL
of	NULL
JAK3	NULL
is	NULL
strongly	NULL
enhanced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
LMP1	NULL
and	NULL
occurs	NULL
within	NULL
minutes	NULL
after	NULL
LMP1	NULL
aggregation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
LMP1	NULL
(	NULL
1.0	NULL
ug	NULL
)	NULL
and	NULL
JAK3	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
expression	NULL
plasmids	NULL
as	NULL
indicated	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
containing	NULL
protease/	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

An	NULL
aliquot	NULL
of	NULL
each	NULL
crude	NULL
extract	NULL
(	NULL
10	NULL
%	NULL
)	NULL
was	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
detected	NULL
using	NULL
the	NULL
PY20/4G10	NULL
antibody	NULL
mix	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

Remaining	NULL
extracts	NULL
were	NULL
immunoprecipitated	NULL
using	NULL
LMP1-specific	NULL
antibodies	NULL
and	NULL
LMP1	NULL
expression	NULL
was	NULL
assessed	NULL
(	NULL
lower	NULL
panel	NULL
!	NULL
)	NULL

.	NULL

(	NULL
B	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
LMP1	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
,	NULL
wild-type	NULL
JAK3	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
,	NULL
or	NULL
dominant-negative	NULL
JAK3AKD	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
in	NULL
the	NULL
combinations	NULL
indicated	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
detected	NULL
as	NULL
described	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmid	NULL
encoding	NULL
LMP1	NULL
(	NULL
1.0	NULL
ug	NULL
)	NULL
,	NULL
NGE-R	NULL
:	NULL
LMP1	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
and	NULL
JAK3	NULL
(	NULL
0.5	NULL
ug	NULL
)	NULL
in	NULL
the	NULL
combinations	NULL
indicated	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
left	NULL
untreated	NULL
(	NULL
un	NULL
)	NULL
,	NULL
incubated	NULL
with	NULL
cross-linking	NULL
antibodies	NULL
(	NULL
+	NULL
)	NULL
,	NULL
or	NULL
with	NULL
secondary	NULL
antibody	NULL
alone	NULL
(	NULL
-	NULL
)	NULL
for	NULL
15	NULL
min	NULL
as	NULL
described	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
detected	NULL
as	NULL
in	NULL
(	NULL
A	NULL
)	NULL
.	NULL

Each	NULL
panel	NULL
shows	NULL
one	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
three	NULL
.	NULL

JAK3	NULL
was	NULL
a	NULL
rapid	NULL
process	NULL
occurring	NULL
within	NULL
15	NULL
min	NULL
after	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
cross-linking	NULL
.	NULL

Continuous	NULL
expression	NULL
of	NULL
wild-type	NULL
LMP1	NULL
resulted	NULL
in	NULL
a	NULL
much	NULL
weaker	NULL
autophosphorylation	NULL
of	NULL
JAK3	NULL
,	NULL
which	NULL
most	NULL
likely	NULL
reflects	NULL
a	NULL
com-binatorial	NULL
effect	NULL
of	NULL
phosphorylation	NULL
and	NULL
subsequent	NULL
activation	NULL
of	NULL
phosphatases	NULL
as	NULL
is	NULL
the	NULL
case	NULL
with	NULL
numerous	NULL
cytokine	NULL
receptors	NULL
(	NULL
Darnell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

This	NULL
finding	NULL
further	NULL
supported	NULL
the	NULL
idea	NULL
that	NULL
LMP1	NULL
directly	NULL
activates	NULL
the	NULL
JAK/	NULL
STAT	NULL
pathway	NULL
as	NULL
short	NULL
term	NULL
cross-linking	NULL
of	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
displayed	NULL
a	NULL
very	NULL
strong	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
3068	NULL
A	NULL
€	NULL
+	NULL
Tet	NULL
+	NULL
CBDag	NULL
Id	NULL
3d	NULL
4d	NULL
Id	NULL
3d	NULL
dd	NULL
d	NULL
€	NULL
(	NULL
UH	NULL
..	NULL
etection	NULL
phospho-SdkD	NULL
_	NULL
tyrosine	NULL
64kD	NULL
1852.4	NULL
cells	NULL
detection	NULL
detection	NULL
133kD	NULL
--	NULL
a-JAK3	NULL
u-phospho-	NULL
%	NULL
tyrosine	NULL
1	NULL
2	NULL
:	NULL
THEE	NULL
.	NULL

5	NULL
g	NULL
40	NULL
s	NULL
&	NULL
=	NULL
4	NULL
t	NULL
=	NULL
a	NULL
a	NULL
ei	NULL
z	NULL
=	NULL
ei	NULL
a	NULL
#	NULL
0	NULL
&	NULL
=	NULL
#	NULL
§	NULL
f	NULL
-	NULL
e	NULL
=	NULL
=	NULL
2	NULL
be	NULL
e	NULL
ci	NULL
a	NULL
ci	NULL
1	NULL
%	NULL
A	NULL
8	NULL
C	NULL
detection	NULL
IYhB	NULL
--	NULL
a-JAK3	NULL
dom	NULL
g	NULL
c-LMP1	NULL
4	NULL
g	NULL
E	NULL
&	NULL
IP	NULL
F	NULL
4	NULL
2	NULL
o	NULL
8	NULL
133kD	NULL
e	NULL
phospho-tyrosine	NULL
IP	NULL
;	NULL
beads	NULL
c-LMPL	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
endogenous	NULL
JAK3	NULL
and	NULL
interaction	NULL
with	NULL
LMP1	NULL
.	NULL

(	NULL
A	NULL
)	NULL
1852.4	NULL
cells	NULL
are	NULL
immortalized	NULL
human	NULL
B	NULL
cells	NULL
carrying	NULL
a	NULL
conditional	NULL
tetracycline	NULL
regulated	NULL
LMP1	NULL
gene	NULL
in	NULL
the	NULL
context	NULL
of	NULL
a	NULL
mini-EBV	NULL
plasmid	NULL
.	NULL

Cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
tetracycline	NULL
for	NULL
four	NULL
days	NULL
(	NULL
-Tet	NULL
)	NULL
which	NULL
leads	NULL
to	NULL
transcriptional	NULL
downregulation	NULL
of	NULL
the	NULL
LMP	NULL
]	NULL
gene	NULL
.	NULL

Subsequently	NULL
,	NULL
LMP1	NULL
expression	NULL
was	NULL
reinduced	NULL
upon	NULL
readdition	NULL
of	NULL
tetracycline	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
for	NULL
up	NULL
to	NULL
four	NULL
days	NULL
(	NULL
+Tet	NULL
)	NULL
.	NULL

Alternatively	NULL
,	NULL
tetracycline	NULL
deprived	NULL
cells	NULL
were	NULL
kept	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CD40-ligand	NULL
expressing	NULL
mouse	NULL
fibroblasts	NULL
(	NULL
+CD40-L	NULL
)	NULL
.	NULL

Cell	NULL
extracts	NULL
from	NULL
1X10	NULL
'	NULL
cells	NULL
were	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
using	NULL
antibodies	NULL
against	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
.	NULL

The	NULL
expected	NULL
size	NULL
of	NULL
JAK3	NULL
is	NULL
indicated	NULL
with	NULL
an	NULL
arrow	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Endogenous	NULL
JAK3	NULL
was	NULL
immunoprecipitated	NULL
from	NULL
proliferating	NULL
1852.4	NULL
cells	NULL
(	NULL
1X10®	NULL
cells	NULL
per	NULL
sample	NULL
)	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
using	NULL
antibodies	NULL
against	NULL
JAK3	NULL
(	NULL
left	NULL
)	NULL
or	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
(	NULL
right	NULL
)	NULL
.	NULL

Crude	NULL
extracts	NULL
from	NULL
293	NULL
cells	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
LMP1	NULL
and	NULL
murine	NULL
JAK3	NULL
were	NULL
analyzed	NULL
in	NULL
parallel	NULL
.	NULL

Direct	NULL
visualization	NULL
of	NULL
ectopically	NULL
expressed	NULL
murine	NULL
JAK3	NULL
in	NULL
293	NULL
cells	NULL
with	NULL
the	NULL
available	NULL
antibodies	NULL
was	NULL
not	NULL
feasible	NULL
which	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
insufficient	NULL
affinity	NULL
of	NULL
the	NULL
JAK3	NULL
antibody	NULL
for	NULL
the	NULL
murine	NULL
protein	NULL
under	NULL
Western	NULL
blot	NULL
conditions	NULL
.	NULL

(	NULL
C	NULL
)	NULL
1852.4	NULL
cells	NULL
(	NULL
1X10®	NULL
cells	NULL
per	NULL
sample	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
and	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
containing	NULL
protease/	NULL
phosphatase	NULL
inhibitors	NULL
.	NULL

Precleared	NULL
cell	NULL
lysates	NULL
were	NULL
immunoprecipitated	NULL
using	NULL
(	NULL
CS1-4	NULL
;	NULL
DAKO	NULL
)	NULL
or	NULL
@	NULL
-JAK3	NULL
(	NULL
C21	NULL
;	NULL
Santa	NULL
Cruz	NULL
)	NULL
antibodies	NULL
.	NULL

Immunoprecipitates	NULL
were	NULL
separated	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
analyzed	NULL
by	NULL
immunoblotting	NULL
using	NULL
G-JAK3	NULL
(	NULL
Santa	NULL
Cruz	NULL
;	NULL
upper	NULL
panel	NULL
)	NULL
or	NULL
G-LMP1	NULL
(	NULL
S12-biotinylated	NULL
;	NULL
middle	NULL
panel	NULL
)	NULL
or	NULL
¢-phosphotyrosine	NULL
(	NULL
PY20/4G10	NULL
;	NULL
lower	NULL
panel	NULL
)	NULL
antibodies	NULL
.	NULL

Each	NULL
panel	NULL
shows	NULL
one	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
.	NULL

in	NULL
the	NULL
absence	NULL
of	NULL
secondary	NULL
downregulating	NULL
events	NULL
(	NULL
e.g	NULL
.	NULL

phosphatase	NULL
activity	NULL
)	NULL
.	NULL

LMP1	NULL
and	NULL
JAK3	NULL
interact	NULL
in	NULL
293	NULL
and	NULL
B	NULL
cells	NULL
The	NULL
most	NULL
obvious	NULL
scenario	NULL
which	NULL
would	NULL
explain	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
by	NULL
LMP1	NULL
is	NULL
the	NULL
direct	NULL
binding	NULL
of	NULL
JAK3	NULL
to	NULL
the	NULL
C-terminal	NULL
domain	NULL
of	NULL
LMP1	NULL
.	NULL

The	NULL
constitutively	NULL
aggregated	NULL
LMP1	NULL
molecules	NULL
would	NULL
tether	NULL
JAK3	NULL
molecules	NULL
to	NULL
the	NULL
plasma	NULL
membrane	NULL
inducing	NULL
them	NULL
in	NULL
a	NULL
constitutive	NULL
manner	NULL
.	NULL

As	NULL
anticipated	NULL
,	NULL
immunoprecipitation	NULL
of	NULL
LMP1	NULL
revealed	NULL
a	NULL
weak	NULL
interaction	NULL
with	NULL
an	NULL
~125	NULL
kDa	NULL
phosphorylated	NULL
protein	NULL
in	NULL
293	NULL
cells	NULL
only	NULL
when	NULL
they	NULL
had	NULL
been	NULL
transfected	NULL
with	NULL
a	NULL
JAK3	NULL
expression	NULL
vector	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
such	NULL
interaction	NULL
was	NULL
observed	NULL
between	NULL
LMP1	NULL
and	NULL
JAK	NULL
1	NULL
or	NULL
JAK2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
strongly	NULL
suggested	NULL
that	NULL
JAK3	NULL
might	NULL
be	NULL
bound	NULL
to	NULL
LMP1	NULL
but	NULL
these	NULL
co-immunoprecipitation	NULL
assays	NULL
were	NULL
based	NULL
on	NULL
overexpression	NULL
of	NULL
both	NULL
LMP	NULL
1	NULL
and	NULL
JAKs	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

To	NULL
make	NULL
use	NULL
of	NULL
a	NULL
less	NULL
artificial	NULL
experimental	NULL
setting	NULL
,	NULL
the	NULL
phosphorylation	NULL
status	NULL
of	NULL
endogenous	NULL
JAK3	NULL
and	NULL
its	NULL
interaction	NULL
with	NULL
LMP1	NULL
were	NULL
investigated	NULL
in	NULL
the	NULL
EBV-immortalized	NULL
B	NULL
cell	NULL
line	NULL
1852.4	NULL
.	NULL

Cells	NULL
were	NULL
deprived	NULL
of	NULL
tetracycline	NULL
in	NULL
order	NULL
to	NULL
downregulate	NULL
LMP1	NULL
expression	NULL
(	NULL
see	NULL
Figure	NULL
2B	NULL
)	NULL
.	NULL

LMP	NULL
1	NULL
re-expression	NULL
was	NULL
achieved	NULL
by	NULL
addition	NULL
of	NULL
tetracycline	NULL
to	NULL
the	NULL
culture	NULL
medium	NULL
.	NULL

Alternatively	NULL
,	NULL
tetracycline-deprived	NULL
cells	NULL
were	NULL
kept	NULL
on	NULL
a	NULL
CD40-L	NULL
expressing	NULL
mouse	NULL
fibroblasts	NULL
feeder	NULL
layer	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Cell	NULL
lysates	NULL
were	NULL
then	NULL
tested	NULL
for	NULL
tyrosine-phosphorylated	NULL
proteins	NULL
by	NULL
immunoblotting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5A	NULL
,	NULL
reinduction	NULL
of	NULL
LMP1	NULL
as	NULL
well	NULL
as	NULL
treatment	NULL
with	NULL
CD4QO-L	NULL
induced	NULL
the	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
several	NULL
cellular	NULL
proteins	NULL
,	NULL
one	NULL
migrating	NULL
with	NULL
an	NULL
apparent	NULL
molecular	NULL
weight	NULL
of	NULL
125	NULL
kDa	NULL
.	NULL

Subsequent	NULL
immunoprecipitation	NULL
with	NULL
a	NULL
JAK3-specific	NULL
antibody	NULL
confirmed	NULL
that	NULL
the	NULL
125	NULL
kDa	NULL
protein	NULL
was	NULL
JAK3	NULL
which	NULL
becomes	NULL
phosphorylated	NULL
at	NULL
tyrosine	NULL
residues	NULL
only	NULL
after	NULL
LMPI1	NULL
re-expression	NULL
or	NULL
CD40	NULL
activation	NULL
.	NULL

Reinduction	NULL
of	NULL
LMPI1	NULL
expression	NULL
did	NULL
not	NULL
alter	NULL
the	NULL
steady-state	NULL
levels	NULL
of	NULL
JAK3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
JAK3	NULL
following	NULL
CD40	NULL
ligation	NULL
has	NULL
been	NULL
reported	NULL
recently	NULL
(	NULL
Hanissian	NULL
and	NULL
Geha	NULL
,	NULL
1997	NULL
)	NULL
,	NULL
supporting	NULL
the	NULL
hypothesis	NULL
of	NULL
the	NULL
functional	NULL
similarity	NULL
between	NULL
LMP1	NULL
and	NULL
CD40	NULL
.	NULL

Further	NULL
experiments	NULL
with	NULL
immunoprecipitated	NULL
JAK3	NULL
from	NULL
cycling	NULL
1852.4	NULL
cells	NULL
showed	NULL
that	NULL
a	NULL
substantial	NULL
amount	NULL
of	NULL
JAK3	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
in	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

Endogenous	NULL
human	NULL
JAK3	NULL
from	NULL
B	NULL
cells	NULL
and	NULL
murine	NULL
JAK3	NULL
expressed	NULL
in	NULL
293	NULL
cells	NULL
migrated	NULL
with	NULL
the	NULL
same	NULL
molecular	NULL
weight	NULL
as	NULL
seen	NULL
with	NULL
an	NULL
anti-phosphotyrosine-specific	NULL
antibody	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

As	NULL
is	NULL
apparent	NULL
in	NULL
the	NULL
control	NULL
lanes	NULL
in	NULL
Figure	NULL
5B	NULL
,	NULL
detection	NULL
of	NULL
ectopically	NULL
expressed	NULL
murine	NULL
JAK3	NULL
in	NULL
293	NULL
cells	NULL
with	NULL
the	NULL
available	NULL
antibodies	NULL
was	NULL
not	NULL
feasible	NULL
.	NULL

This	NULL
is	NULL
probably	NULL
due	NULL
to	NULL
the	NULL
insufficient	NULL
affinity	NULL
of	NULL
the	NULL
JAK3	NULL
antibody	NULL
for	NULL
the	NULL
murine	NULL
protein	NULL
under	NULL
Western	NULL
blot	NULL
conditions	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
interaction	NULL
of	NULL
LMP1	NULL
and	NULL
JAK3	NULL
in	NULL
more	NULL
detail	NULL
,	NULL
1852.4	NULL
cells	NULL
were	NULL
grown	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
tetracycline	NULL
to	NULL
permit	NULL
LMP1	NULL
expression	NULL
and	NULL
cell	NULL
proliferation	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

A	NULL
total	NULL
of	NULL
1X10°	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
LMP1	NULL
was	NULL
precipitated	NULL
using	NULL
a	NULL
mix	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
specific	NULL
for	NULL
LMP1	NULL
(	NULL
CS1-4	NULL
)	NULL
.	NULL

Precipitated	NULL
proteins	NULL
were	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
,	NULL
and	NULL
co-precipitated	NULL
JAK3	NULL
was	NULL
detected	NULL
using	NULL
an	NULL
G-JAK3	NULL
antibody	NULL
after	NULL
Western	NULL
blotting	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
5C	NULL
,	NULL
JAK3	NULL
co-precipitated	NULL
with	NULL
LMP1	NULL
,	NULL
demonstrating	NULL
that	NULL
LMP1	NULL
and	NULL
endogenous	NULL
JAK3	NULL
LMP1	NULL
activates	NULL
JAK/STAT	NULL
physically	NULL
interact	NULL
in	NULL
EBV	NULL
immortalized	NULL
B	NULL
cells	NULL
.	NULL

Incubation	NULL
of	NULL
cell	NULL
lysates	NULL
with	NULL
beads	NULL
alone	NULL
(	NULL
or	NULL
with	NULL
an	NULL
o-NGF-R	NULL
anti-body	NULL
;	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
precipitated	NULL
neither	NULL
JAK3	NULL
nor	NULL
LMP	NULL
1	NULL
.	NULL

Reciprocally	NULL
,	NULL
LMP1	NULL
was	NULL
also	NULL
detectable	NULL
in	NULL
immunoprecipitates	NULL
as	NULL
shown	NULL
in	NULL
Figure	NULL
5C	NULL
.	NULL

We	NULL
could	NULL
further	NULL
show	NULL
that	NULL
LMP1	NULL
associated	NULL
JAK3	NULL
is	NULL
tyrosine	NULL
phosphorylated	NULL
(	NULL
Figure	NULL
5C	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
as	NULL
anticipated	NULL
from	NULL
the	NULL
cotransfection	NULL
experiments	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
Figure	NULL
4	NULL
)	NULL
.	NULL

These	NULL
results	NULL
clearly	NULL
demonstrate	NULL
that	NULL
endogenous	NULL
LMP1	NULL
and	NULL
JAK3	NULL
interact	NULL
in	NULL
vivo	NULL
in	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
,	NULL
which	NULL
is	NULL
the	NULL
most	NULL
likely	NULL
molecular	NULL
basis	NULL
for	NULL
JAK3	NULL
phosphorylation	NULL
and	NULL
activation	NULL
by	NULL
LMP1	NULL
.	NULL

The	NULL
JAK3	NULL
activation	NULL
domain	NULL
maps	NULL
to	NULL
the	NULL
box1	NULL
motifs	NULL
within	NULL
the	NULL
repetitive	NULL
region	NULL
of	NULL
LMP1	NULL
The	NULL
C-terminus	NULL
of	NULL
LMP1	NULL
was	NULL
sufficient	NULL
for	NULL
the	NULL
rapid	NULL
activation	NULL
of	NULL
JAK3	NULL
and	NULL
STAT	NULL
proteins	NULL
(	NULL
Figures	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

To	NULL
confirm	NULL
our	NULL
initial	NULL
hypothesis	NULL
of	NULL
JAK	NULL
activation	NULL
via	NULL
the	NULL
box	NULL
1	NULL
motifs	NULL
of	NULL
LMP1	NULL
,	NULL
we	NULL
generated	NULL
a	NULL
LMP	NULL
1	NULL
mutant	NULL
that	NULL
lacked	NULL
the	NULL
entire	NULL
JAK-binding	NULL
sequences	NULL
,	NULL
as	NULL
depicted	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

This	NULL
mutant	NULL
,	NULL
termed	NULL
LMP1A33bp	NULL
,	NULL
was	NULL
transiently	NULL
transfected	NULL
in	NULL
293	NULL
cells	NULL
together	NULL
with	NULL
the	NULL
JAK3	NULL
expression	NULL
vector	NULL
and	NULL
tyrosine	NULL
autophosphorylation	NULL
of	NULL
JAK3	NULL
was	NULL
analyzed	NULL
.	NULL

Both	NULL
wild-type	NULL
LMP1	NULL
and	NULL
LMP1A33bp	NULL
were	NULL
expressed	NULL
as	NULL
FLAG	NULL
epitope-tagged	NULL
variants	NULL
to	NULL
permit	NULL
the	NULL
detection	NULL
of	NULL
both	NULL
proteins	NULL
with	NULL
equal	NULL
sensitivity	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Figure	NULL
6A	NULL
,	NULL
FLAG-tagged	NULL
LMP1A33bp	NULL
(	NULL
F-LMP1A33bp	NULL
)	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
the	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
at	NULL
tyrosine	NULL
residues	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
FLAG-tagged	NULL
wild-type	NULL
LMP1	NULL
(	NULL
F-LMP1	NULL
)	NULL
,	NULL
although	NULL
both	NULL
molecules	NULL
were	NULL
expressed	NULL
at	NULL
comparable	NULL
levels	NULL
(	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

The	NULL
modifications	NULL
in	NULL
F-LMP1A33bp	NULL
had	NULL
no	NULL
consequences	NULL
in	NULL
terms	NULL
of	NULL
activation	NULL
of	NULL
the	NULL
c-jun	NULL
N-terminal	NULL
kinase	NULL
1	NULL
pathway	NULL
(	NULL
Figure	NULL
6B	NULL
)	NULL
or	NULL
induction	NULL
of	NULL
NF-KB	NULL
as	NULL
anticipated	NULL
(	NULL
Figure	NULL
6C	NULL
)	NULL
.	NULL

This	NULL
was	NULL
expected	NULL
since	NULL
neither	NULL
CTAR1	NULL
nor	NULL
CTAR2	NULL
are	NULL
affected	NULL
by	NULL
the	NULL
deletion	NULL
in	NULL
F-LMP1A33bp	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
LMP1A33bp	NULL
mutation	NULL
displays	NULL
a	NULL
very	NULL
discrete	NULL
phenotype	NULL
that	NULL
selectively	NULL
affects	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
.	NULL

Next	NULL
,	NULL
we	NULL
selectively	NULL
reconstituted	NULL
the	NULL
deleted	NULL
repeats	NULL
within	NULL
the	NULL
LMP1A33bp	NULL
mutant	NULL
using	NULL
oligonucleotides	NULL
encoding	NULL
either	NULL
the	NULL
simple	NULL
33	NULL
bp	NULL
repeat	NULL
lacking	NULL
the	NULL
box	NULL
1	NULL
motif	NULL
or	NULL
the	NULL
PXXPXP	NULL
box	NULL
1	NULL
motif	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
more	NULL
complex	NULL
repeat	NULL
unit	NULL
(	NULL
see	NULL
Figure	NULL
1	NULL
for	NULL
the	NULL
differences	NULL
)	NULL
.	NULL

The	NULL
purpose	NULL
of	NULL
this	NULL
reconstitution	NULL
experiment	NULL
was	NULL
to	NULL
perform	NULL
the	NULL
fine	NULL
mapping	NULL
of	NULL
the	NULL
JAK3	NULL
activation	NULL
domain	NULL
within	NULL
LMP1	NULL
.	NULL

Reconstituted	NULL
mutants	NULL
containing	NULL
one	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
different	NULL
repetitive	NULL
sequences	NULL
were	NULL
expressed	NULL
in	NULL
293	NULL
cells	NULL
together	NULL
with	NULL
JAK3	NULL
followed	NULL
by	NULL
immunoblotting	NULL
to	NULL
detect	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
.	NULL

Enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
was	NULL
observed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
wild-type	NULL
LMP1	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
,	NULL
which	NULL
was	NULL
strongly	NULL
impaired	NULL
in	NULL
the	NULL
case	NULL
of	NULL
the	NULL
LMP1A33bp	NULL
mutant	NULL
as	NULL
seen	NULL
before	NULL
(	NULL
see	NULL
Figure	NULL
6A	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
reintroduction	NULL
of	NULL
box	NULL
1	NULL
motif	NULL
sequences	NULL
had	NULL
a	NULL
phenotype	NULL
almost	NULL
comparable	NULL
with	NULL
wild-type	NULL
LMP	NULL
1	NULL
in	NULL
terms	NULL
of	NULL
JAK3	NULL
phosphorylation	NULL
.	NULL

Reintroduction	NULL
of	NULL
the	NULL
simple	NULL
33	NULL
bp	NULL
repeat	NULL
lacking	NULL
the	NULL
box	NULL
1	NULL
consensus	NULL
motif	NULL
led	NULL
to	NULL
a	NULL
mediocre	NULL
but	NULL
clearly	NULL
detectable	NULL
increase	NULL
of	NULL
JAK3	NULL
phosphorylation	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

This	NULL
effect	NULL
could	NULL
be	NULL
due	NULL
to	NULL
the	NULL
presence	NULL
of	NULL
box	NULL
1-like	NULL
sequences	NULL
(	NULL
PXXP	NULL
)	NULL
within	NULL
the	NULL
simple	NULL
33	NULL
bp	NULL
repeats	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
or	NULL
surrounding	NULL
sequences	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
JAK3	NULL
activation	NULL
domain	NULL
maps	NULL
primarily	NULL
to	NULL
the	NULL
box	NULL
1	NULL
motifs	NULL
located	NULL
within	NULL
the	NULL
repetitive	NULL
array	NULL
of	NULL
LMP1	NULL
although	NULL
surrounding	NULL
sequences	NULL
seem	NULL
to	NULL
contribute	NULL
to	NULL
3069	NULL
O.Gires	NULL
et	NULL
al	NULL
.	NULL

%	NULL
IJJkI5I—	NULL
:	NULL
_	NULL
m	NULL
a+	NULL
Ath	NULL
67kD	NULL
a-P¥	NULL
_	NULL
;	NULL
|	NULL
ii	NULL
“	NULL
.q	NULL
***	NULL
!	NULL

__	NULL
sip	NULL
OFLAC	NULL
$	NULL
5	NULL
:	NULL
;	NULL
t	NULL
:	NULL
f	NULL
&	NULL
o£	NULL
=	NULL
m	NULL
m	NULL
m	NULL
&	NULL
3	NULL
§	NULL
f	NULL
§	NULL
4	NULL
3	NULL
3	NULL
i	NULL
0	NULL
E	NULL
&	NULL
E	NULL
i	NULL
E	NULL
&	NULL
=	NULL
=	NULL
w.	NULL
N	NULL
th	NULL
HA-JNK1	NULL
activity	NULL
_	NULL
,	NULL
(	NULL
GST-c-Jun-P	NULL
)	NULL
‘	NULL
-	NULL
HA-JNK1	NULL
IP	NULL
(	NULL
immunoblot	NULL
)	NULL
**	NULL
'-	NULL
a	NULL
»	NULL
aih	NULL
ax	NULL
gm	NULL
&	NULL
&	NULL
transfected	NULL
DNAs	NULL
:	NULL
E	NULL
=	NULL
g	NULL
m	NULL
P	NULL
=	NULL
.	NULL

C	NULL
1	NULL
NF-xB	NULL
fold	NULL
incluetion	NULL
*	NULL
if	NULL
in	NULL
5	NULL
fel	NULL
___	NULL
a	NULL
moc	NULL
F-LMP1	NULL
F-LMP1A33bp	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
FLAG-LMP1A33bp	NULL
or	NULL
FLAG-LMP1	NULL
.	NULL

The	NULL
LMP1A33bp	NULL
mutant	NULL
of	NULL
LMP1	NULL
fails	NULL
to	NULL
induce	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
although	NULL
it	NULL
is	NULL
as	NULL
effective	NULL
as	NULL
wild-type	NULL
LMP1	NULL
with	NULL
respect	NULL
to	NULL
NF-KB	NULL
and	NULL
JNK1	NULL
activation	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
:	NULL
293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
the	NULL
FLAG-epitope	NULL
tagged	NULL
variant	NULL
of	NULL
wild-type	NULL
LMP1	NULL
(	NULL
F-LMP1	NULL
)	NULL
or	NULL
LMP1A33bp	NULL
(	NULL
F-LMP1A33bp	NULL
)	NULL
(	NULL
0.1	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
murine	NULL
JAK3	NULL
(	NULL
0.3	NULL
ug	NULL
)	NULL
.	NULL

Tyrosine	NULL
phosphorylated	NULL
proteins	NULL
were	NULL
detected	NULL
as	NULL
described	NULL
(	NULL
left	NULL
panel	NULL
)	NULL
.	NULL

Equal	NULL
expression	NULL
of	NULL
FLAG-LMP1	NULL
and	NULL
FLAG-LMP1A33bp	NULL
was	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
with	NULL
M2-FLAG	NULL
antibody	NULL
in	NULL
combination	NULL
with	NULL
HRP-conjugated	NULL
secondary	NULL
antibody	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Activation	NULL
of	NULL
JNK1	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
FLAG-epitope	NULL
tagged	NULL
variants	NULL
of	NULL
LMP1	NULL
or	NULL
LMP1A33bp	NULL
(	NULL
0.125	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
HA-tagged	NULL
JNK1	NULL
(	NULL
1	NULL
ug	NULL
)	NULL
.	NULL

Kinase	NULL
activity	NULL
of	NULL
immunoprecipitated	NULL
JNK1	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
was	NULL
assessed	NULL
as	NULL
described	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
HA-INK1	NULL
was	NULL
equal	NULL
as	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
with	NULL
@	NULL
-JNK1	NULL
antibody	NULL
(	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Activation	NULL
of	NULL
NF-KB	NULL
.	NULL

293	NULL
cells	NULL
were	NULL
transiently	NULL
transfected	NULL
with	NULL
expression	NULL
plasmids	NULL
for	NULL
FLAG	NULL
epitope-tagged	NULL
LMP1	NULL
or	NULL
LMP1A33bp	NULL
(	NULL
0.125	NULL
ug	NULL
)	NULL
together	NULL
with	NULL
an	NULL
NF-KB	NULL
reporter	NULL
plasmid	NULL
(	NULL
5	NULL
ng	NULL
)	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
one	NULL
day	NULL
after	NULL
transfection	NULL
and	NULL
normalized	NULL
for	NULL
B-galactosidase	NULL
activity	NULL
.	NULL

One	NULL
experiment	NULL
out	NULL
of	NULL
two	NULL
is	NULL
shown	NULL
in	NULL
(	NULL
B	NULL
)	NULL
and	NULL
(	NULL
C	NULL
)	NULL
.	NULL

maximal	NULL
JAK3	NULL
autophosphorylation	NULL
.	NULL

Unexpectedly	NULL
,	NULL
the	NULL
repeat	NULL
copy	NULL
number	NULL
had	NULL
no	NULL
discernible	NULL
effect	NULL
.	NULL

Discussion	NULL
In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
potential	NULL
of	NULL
LMPI1	NULL
to	NULL
induce	NULL
cellular	NULL
signaling	NULL
cascades	NULL
besides	NULL
those	NULL
leading	NULL
to	NULL
NF-KB	NULL
and	NULL
AP-1	NULL
activation	NULL
.	NULL

It	NULL
has	NULL
been	NULL
shown	NULL
recently	NULL
that	NULL
LMP	NULL
1	NULL
is	NULL
a	NULL
constitutively	NULL
active	NULL
pseudo-receptor	NULL
(	NULL
Gires	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Hatzivassiliou	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
that	NULL
acts	NULL
as	NULL
a	NULL
key	NULL
player	NULL
during	NULL
B	NULL
cell	NULL
immortalization	NULL
(	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
3070	NULL
+	NULL
JAK3	NULL
Detection	NULL
a-phospho-	NULL
|	NULL
Mh	NULL
wih	NULL
-	NULL
lh	NULL
tyrosine	NULL
mock	NULL
only	NULL
JAK3	NULL
F-LMP1	NULL
F-LMP1/2x33bp	NULL
~LMP1/2xbox1	NULL
H.	NULL
F-LMPI/1Ixbox1	NULL
if	NULL
F-LMP1A33bp	NULL
F-LMPL1x33bp	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

JAK3-activation	NULL
domain	NULL
primarily	NULL
maps	NULL
to	NULL
the	NULL
box	NULL
1	NULL
motif	NULL
.	NULL

To	NULL
evaluate	NULL
the	NULL
function	NULL
of	NULL
the	NULL
different	NULL
repetitive	NULL
sequences	NULL
for	NULL
JAK3	NULL
activation	NULL
,	NULL
FLAG-LMP1A33bp	NULL
(	NULL
F-LMP1A33bp	NULL
)	NULL
lacking	NULL
the	NULL
entire	NULL
33	NULL
bp	NULL
repeat	NULL
region	NULL
was	NULL
reconstituted	NULL
with	NULL
synthetic	NULL
oligonucleotides	NULL
.	NULL

They	NULL
encode	NULL
one	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
simple	NULL
33	NULL
bp	NULL
repeat	NULL
(	NULL
F-LMP1/1	NULL
X33bp	NULL
and	NULL
F-LMP1/2X33bp	NULL
)	NULL
or	NULL
the	NULL
longer	NULL
repeat	NULL
encompassing	NULL
the	NULL
box	NULL
1	NULL
motif	NULL
(	NULL
FE-LMP1/1	NULL
Xbox1	NULL
and	NULL
E-LMPI/	NULL
2Xbox1	NULL
)	NULL
as	NULL
described	NULL
in	NULL
Material	NULL
and	NULL
methods	NULL
.	NULL

Expression	NULL
plasmids	NULL
for	NULL
each	NULL
LMP1	NULL
variant	NULL
were	NULL
transfected	NULL
together	NULL
with	NULL
JAK3	NULL
in	NULL
293	NULL
cells	NULL
.	NULL

One	NULL
day	NULL
after	NULL
transfection	NULL
cells	NULL
were	NULL
lysed	NULL
and	NULL
tyrosine	NULL
phosphorylation	NULL
was	NULL
assessed	NULL
by	NULL
immunoblotting	NULL
(	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
levels	NULL
of	NULL
each	NULL
LMP1	NULL
variant	NULL
were	NULL
comparable	NULL
as	NULL
revealed	NULL
by	NULL
immunoblotting	NULL
with	NULL
FLAG	NULL
epitope-specific	NULL
antibodies	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
out	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

1996	NULL
;	NULL
Izumi	NULL
and	NULL
Kieff	NULL
,	NULL
1997	NULL
;	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

So	NULL
far	NULL
,	NULL
two	NULL
signaling	NULL
domains	NULL
have	NULL
been	NULL
identified	NULL
,	NULL
termed	NULL
C-terminal	NULL
activating	NULL
region	NULL
1	NULL
and	NULL
2	NULL
(	NULL
CTAR	NULL
1	NULL
and	NULL
CTAR2	NULL
)	NULL
(	NULL
Huen	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
which	NULL
interact	NULL
with	NULL
TRAFs	NULL
(	NULL
Sandberg	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
and	NULL
TRADD	NULL
(	NULL
Izumi	NULL
and	NULL
Kieff	NULL
,	NULL
1997	NULL
;	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
,	NULL
respectively	NULL
,	NULL
and	NULL
account	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
AP-1	NULL
and	NULL
NF-KB	NULL
(	NULL
Mitchell	NULL
and	NULL
Sugden	NULL
,	NULL
1995	NULL
;	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
)	NULL
.	NULL

No	NULL
function	NULL
could	NULL
be	NULL
assigned	NULL
to	NULL
the	NULL
fairly	NULL
large	NULL
remaining	NULL
parts	NULL
of	NULL
the	NULL
C-terminus	NULL
of	NULL
LMP1	NULL
.	NULL

Here	NULL
,	NULL
we	NULL
identified	NULL
a	NULL
third	NULL
C-terminal	NULL
activating	NULL
region	NULL
located	NULL
between	NULL
CTAR1	NULL
and	NULL
CTAR2	NULL
(	NULL
Figure	NULL
1	NULL
)	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
LMP1I	NULL
and	NULL
JAK3	NULL
interact	NULL
following	NULL
the	NULL
ectopic	NULL
expression	NULL
of	NULL
both	NULL
molecules	NULL
in	NULL
293	NULL
cells	NULL
while	NULL
no	NULL
interaction	NULL
was	NULL
detected	NULL
between	NULL
LMP1l	NULL
and	NULL
JAK	NULL
!	NULL

or	NULL
JAK2	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

More	NULL
importantly	NULL
,	NULL
LMP1	NULL
and	NULL
JAK3	NULL
also	NULL
strongly	NULL
interact	NULL
in	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

This	NULL
protein-protein	NULL
interaction	NULL
leads	NULL
to	NULL
the	NULL
enhanced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
JAK3	NULL
,	NULL
which	NULL
is	NULL
a	NULL
hallmark	NULL
for	NULL
its	NULL
activation	NULL
(	NULL
Figures	NULL
4	NULL
and	NULL
5	NULL
)	NULL
,	NULL
and	NULL
activation	NULL
of	NULL
STAT	NULL
1	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
and	NULL
STAT3	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
as	NULL
indicated	NULL
by	NULL
their	NULL
induced	NULL
phosphorylation	NULL
and	NULL
DNA-binding	NULL
capacity	NULL
.	NULL

In	NULL
line	NULL
with	NULL
our	NULL
findings	NULL
,	NULL
JAK3	NULL
and	NULL
Tyk2	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
constitutively	NULL
phosphorylated	NULL
in	NULL
EBV-immortalized	NULL
B	NULL
cells	NULL
(	NULL
Murata	NULL
and	NULL
Puri	NULL
,	NULL
1997	NULL
)	NULL
,	NULL
as	NULL
was	NULL
JAK3	NULL
in	NULL
T	NULL
cells	NULL
immortalized	NULL
by	NULL
HTLV1	NULL
(	NULL
Xu	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

As	NULL
a	NULL
consequence	NULL
,	NULL
the	NULL
downstream	NULL
targets	NULL
of	NULL
JAK3	NULL
,	NULL
STAT1	NULL
and	NULL
STAT3	NULL
also	NULL
acquire	NULL
a	NULL
permanent	NULL
activation	NULL
state	NULL
in	NULL
lymphoblastoid	NULL
cell	NULL
lines	NULL
and	NULL
in	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
(	NULL
Weber-Nordt	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
)	NULL
.	NULL

Mutational	NULL
analysis	NULL
allowed	NULL
the	NULL
mapping	NULL
of	NULL
LMPI	NULL
's	NULL
activation	NULL
domain	NULL
to	NULL
the	NULL
box	NULL
1	NULL
consensus	NULL
motifs	NULL
(	NULL
PXXPXP	NULL
)	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
33	NULL
bp	NULL
repeats	NULL
of	NULL
LMP1	NULL
(	NULL
Figure	NULL
6	NULL
)	NULL
with	NULL
surrounding	NULL
sequences	NULL
contributing	NULL
to	NULL
the	NULL
activation	NULL
domain	NULL
(	NULL
Figure	NULL
7	NULL
)	NULL
.	NULL

In	NULL
accordance	NULL
with	NULL
LMP	NULL
1	NULL
's	NULL
nomenclature	NULL
we	NULL
would	NULL
suggest	NULL
naming	NULL
this	NULL
newly	NULL
identified	NULL
functional	NULL
domain	NULL
CTAR3	NULL
.	NULL

In	NULL
B	NULL
cells	NULL
immortalized	NULL
with	NULL
a	NULL
mini-EBV	NULL
carrying	NULL
a	NULL
conditional	NULL
LMP1	NULL
allele	NULL
we	NULL
could	NULL
demonstrate	NULL
that	NULL
the	NULL
expression	NULL
of	NULL
LMP	NULL
1	NULL
induced	NULL
STAT	NULL
1	NULL
DNA-binding	NULL
activity	NULL
(	NULL
Figure	NULL
2	NULL
)	NULL
.	NULL

In	NULL
293	NULL
cells	NULL
,	NULL
cross-linking	NULL
of	NULL
the	NULL
NGF-R	NULL
:	NULL
LMP1	NULL
chimera	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
JAK3	NULL
led	NULL
to	NULL
the	NULL
appearance	NULL
of	NULL
a	NULL
similar	NULL
band	NULL
shift	NULL
complex	NULL
within	NULL
minutes	NULL
(	NULL
Figure	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
our	NULL
initial	NULL
data	NULL
indicated	NULL
that	NULL
LMP1	NULL
induced	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
STAT3	NULL
in	NULL
293	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
LMP1	NULL
expression	NULL
in	NULL
the	NULL
1852.4	NULL
B	NULL
cell	NULL
line	NULL
and	NULL
in	NULL
293	NULL
cells	NULL
clearly	NULL
induced	NULL
STAT	NULL
DNA	NULL
binding	NULL
as	NULL
a	NULL
function	NULL
of	NULL
JAK3	NULL
activation	NULL
.	NULL

The	NULL
kinetics	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
activated	NULL
by	NULL
LMP1	NULL
were	NULL
reminiscent	NULL
of	NULL
cytokine	NULL
receptors	NULL
and	NULL
occurred	NULL
rapidly	NULL
which	NULL
might	NULL
represent	NULL
a	NULL
very	NULL
early	NULL
event	NULL
in	NULL
LMP1	NULL
signaling	NULL
,	NULL
predisposing	NULL
the	NULL
cell	NULL
for	NULL
additional	NULL
proliferation	NULL
signals	NULL
.	NULL

In	NULL
the	NULL
EBV-immortalized	NULL
B	NULL
cell	NULL
line	NULL
1852.4	NULL
induction	NULL
of	NULL
STAT	NULL
DNA-binding	NULL
activity	NULL
peaked	NULL
at	NULL
day	NULL
1	NULL
but	NULL
was	NULL
still	NULL
substantial	NULL
at	NULL
day	NULL
4	NULL
of	NULL
LMP1	NULL
re-expression	NULL
.	NULL

The	NULL
rapid	NULL
downregulation	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
after	NULL
its	NULL
induction	NULL
is	NULL
a	NULL
common	NULL
feature	NULL
of	NULL
cytokine	NULL
signaling	NULL
.	NULL

The	NULL
actual	NULL
induction	NULL
level	NULL
of	NULL
the	NULL
JAK/STAT	NULL
signaling	NULL
cascade	NULL
is	NULL
accepted	NULL
to	NULL
be	NULL
the	NULL
result	NULL
of	NULL
activation	NULL
of	NULL
PTK	NULL
in	NULL
conjunction	NULL
with	NULL
counter-regulation	NULL
by	NULL
phosphatases	NULL
and/or	NULL
predisposition	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
STATs	NULL
for	NULL
the	NULL
ubiquitin	NULL
degradation	NULL
pathway	NULL
(	NULL
Darnell	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Previous	NULL
work	NULL
from	NULL
our	NULL
group	NULL
demonstrated	NULL
that	NULL
the	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
JNK1	NULL
occurs	NULL
predominantly	NULL
between	NULL
days	NULL
2	NULL
and	NULL
3	NULL
in	NULL
1852	NULL
B	NULL
cells	NULL
(	NULL
Kieser	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1997	NULL
;	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
JAK/STAT	NULL
activation	NULL
is	NULL
a	NULL
fast	NULL
event	NULL
following	NULL
LMP1	NULL
expression	NULL
.	NULL

The	NULL
JAK/STAT	NULL
pathway	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
be	NULL
important	NULL
in	NULL
several	NULL
cellular	NULL
decisions	NULL
such	NULL
as	NULL
proliferation	NULL
and	NULL
protection	NULL
from	NULL
apoptosis	NULL
in	NULL
Baf3	NULL
lymphoid	NULL
cells	NULL
(	NULL
Rodriguez	NULL
Tarduchy	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1990	NULL
;	NULL
Leonard	NULL
and	NULL
O'Shea	NULL
,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
relevance	NULL
of	NULL
JAK3	NULL
in	NULL
cell	NULL
fate	NULL
decisions	NULL
is	NULL
especially	NULL
highlighted	NULL
by	NULL
the	NULL
finding	NULL
of	NULL
JAK3	NULL
deficiency	NULL
in	NULL
SCID	NULL
patients	NULL
where	NULL
it	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
human	NULL
lymphoid	NULL
development	NULL
(	NULL
Macchi	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
;	NULL
Russell	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
its	NULL
ability	NULL
to	NULL
induce	NULL
DNA	NULL
synthesis	NULL
and	NULL
proto-oncogenes	NULL
such	NULL
as	NULL
c-myc	NULL
and	NULL
c-fos	NULL
(	NULL
Kawahara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
,	NULL
and	NULL
the	NULL
contribution	NULL
of	NULL
STATs	NULL
to	NULL
prevent	NULL
apoptosis	NULL
in	NULL
multiple	NULL
myelomas	NULL
(	NULL
Catlett-Falcone	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1999	NULL
)	NULL
.	NULL

The	NULL
activation	NULL
of	NULL
the	NULL
JAK/STAT	NULL
pathway	NULL
may	NULL
therefore	NULL
contribute	NULL
to	NULL
LMP1	NULL
's	NULL
ability	NULL
to	NULL
transform	NULL
cells	NULL
and/or	NULL
protect	NULL
B	NULL
cells	NULL
from	NULL
apoptosis	NULL
in	NULL
the	NULL
context	NULL
of	NULL
an	NULL
EBV	NULL
infection	NULL
.	NULL

One	NULL
could	NULL
envision	NULL
that	NULL
the	NULL
simultaneous	NULL
or	NULL
sequential	NULL
activation	NULL
of	NULL
NF-KB	NULL
,	NULL
AP-1	NULL
,	NULL
JAK/STAT	NULL
(	NULL
and	NULL
possibly	NULL
others	NULL
)	NULL
is	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
potential	NULL
of	NULL
LMP1	NULL
to	NULL
induce	NULL
growth	NULL
transformation	NULL
,	NULL
expression	NULL
of	NULL
cellular	NULL
surface	NULL
markers	NULL
,	NULL
and	NULL
B	NULL
cell	NULL
immortalization	NULL
.	NULL

The	NULL
recruitment	NULL
of	NULL
signal	NULL
transducing	NULL
molecules	NULL
and	NULL
the	NULL
balance	NULL
between	NULL
these	NULL
signals	NULL
will	NULL
influence	NULL
cell	NULL
fate	NULL
into	NULL
one	NULL
or	NULL
the	NULL
other	NULL
direction	NULL
,	NULL
promoting	NULL
cell	NULL
death	NULL
or	NULL
proliferation	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
interaction	NULL
between	NULL
the	NULL
CD40	NULL
receptor	NULL
and	NULL
JAK3	NULL
was	NULL
demonstrated	NULL
to	NULL
be	NULL
important	NULL
for	NULL
the	NULL
induction	NULL
of	NULL
cellular	NULL
surface	NULL
markers	NULL
such	NULL
as	NULL
CD23	NULL
,	NULL
ICAM-1	NULL
and	NULL
LT-o	NULL
(	NULL
Hanissian	NULL
and	NULL
Geha	NULL
,	NULL
1997	NULL
)	NULL
.	NULL

Although	NULL
LMP1	NULL
and	NULL
CD40	NULL
do	NULL
not	NULL
display	NULL
a	NULL
convincing	NULL
overall	NULL
homology	NULL
at	NULL
the	NULL
primary	NULL
amino	NULL
acid	NULL
sequence	NULL
level	NULL
,	NULL
they	NULL
have	NULL
analogous	NULL
functions	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
Zimber-Strobl	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1996	NULL
;	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
seems	NULL
conceivable	NULL
that	NULL
binding	NULL
and	NULL
constitutive	NULL
activation	NULL
of	NULL
JAK3	NULL
by	NULL
LMP1	NULL
upregulates	NULL
the	NULL
same	NULL
cellular	NULL
genes	NULL
as	NULL
CD40	NULL
when	NULL
activated	NULL
by	NULL
its	NULL
specific	NULL
ligand	NULL
.	NULL

The	NULL
identification	NULL
of	NULL
downstream	NULL
target	NULL
genes	NULL
of	NULL
STATs	NULL
will	NULL
be	NULL
essential	NULL
to	NULL
reveal	NULL
the	NULL
mode	NULL
of	NULL
action	NULL
of	NULL
LMP1	NULL
as	NULL
a	NULL
complex	NULL
,	NULL
multipotent	NULL
pseudo-receptor	NULL
.	NULL

With	NULL
the	NULL
development	NULL
of	NULL
recent	NULL
techniques	NULL
(	NULL
Delecluse	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
,	NULL
1999	NULL
)	NULL
,	NULL
LMP1	NULL
activates	NULL
JAK/STAT	NULL
genetic	NULL
experiments	NULL
are	NULL
now	NULL
feasible	NULL
to	NULL
study	NULL
the	NULL
contribution	NULL
of	NULL
the	NULL
different	NULL
domains	NULL
within	NULL
the	NULL
C-terminus	NULL
of	NULL
LMP1	NULL
with	NULL
respect	NULL
to	NULL
efficient	NULL
B-cell	NULL
immortalization	NULL
by	NULL
EBV	NULL
.	NULL

Materials	NULL
and	NULL
methods	NULL
Plasmid	NULL
DNAs	NULL
Wild-type	NULL
LMP1	NULL
and	NULL
NGE-R	NULL
:	NULL
LMP1	NULL
were	NULL
expressed	NULL
from	NULL
the	NULL
SV40	NULL
promoter/enhancer	NULL
in	NULL
pHEBo	NULL
(	NULL
Yates	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1985	NULL
)	NULL
.	NULL

Full-length	NULL
wild-type	NULL
LMP1	NULL
was	NULL
expressed	NULL
as	NULL
a	NULL
fusion	NULL
with	NULL
the	NULL
FLAG	NULL
epitope	NULL
expressed	NULL
from	NULL
the	NULL
CMV	NULL
promoter	NULL
in	NULL
the	NULL
FLAG-CMV2	NULL
expression	NULL
plasmid	NULL
(	NULL
IBI-Kodak	NULL
)	NULL
.	NULL

To	NULL
create	NULL
the	NULL
mutant	NULL
plasmid	NULL
FLAG-LMP1A33bp	NULL
,	NULL
the	NULL
repetitive	NULL
sequences	NULL
in	NULL
FLAG-LMP1	NULL
were	NULL
deleted	NULL
.	NULL

A	NULL
double-stranded	NULL
synthetic	NULL
oligonucleotide	NULL
(	NULL
upstream	NULL
oligonucleotide	NULL
:	NULL
5'-GGGGCCGG-GCGACGGACCCCCACTCTGCTCTCAAAACCTAGGCGCACCTG-	NULL
downstream	NULL
oligonucleotide	NULL
:	NULL
5'-CCCCAATTGTGGAGGGCCTCCATCATTTCCAGCAGAGT-CGCTAGGGCTATGAGATCTAGGACCACCTCCAGGTGCGCC-3	NULL
'	NULL
)	NULL
was	NULL
inserted	NULL
into	NULL
FLAG-LMP1	NULL
which	NULL
had	NULL
been	NULL
cleaved	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
and	NULL
Munl	NULL
.	NULL

FLAG-LMP1/1X33bp	NULL
and	NULL
FLAG-LMPI	NULL
2X33bp	NULL
are	NULL
based	NULL
on	NULL
FLAG-LMP1A33bp	NULL
and	NULL
contain	NULL
one	NULL
or	NULL
two	NULL
pairs	NULL
of	NULL
oligonucleotides	NULL
inserted	NULL
into	NULL
the	NULL
Xbal-cleaved	NULL
plasmid	NULL
(	NULL
upstream	NULL
oligonucleotide	NULL
:	NULL
5'-CTAGCGACAATGGCCCACAGGACCCTGACA-ACACTGATT-3	NULL
'	NULL
;	NULL
downstream	NULL
oligonucleotide	NULL
:	NULL
5'-CTAGAATCAGTG-TTGTCAGGGTCCTGTGGGCCATTGTCG-3	NULL
``	NULL
)	NULL
.	NULL

FLAG-LMP1/1	NULL
Xbox1	NULL
and	NULL
FLAG-LMP1/2Xbox1	NULL
were	NULL
generated	NULL
similarly	NULL
(	NULL
upstream	NULL
oligonucleotide	NULL
:	NULL
5'-CTAGCGACAATGGCCCACATGACCCGCTGCCTCA-GGACCCTGACAACACTGATT-3	NULL
'	NULL
;	NULL
downstream	NULL
oligonucleotide	NULL
:	NULL
5'-CTAGAATCAGTGTTGTCAGGGTCCTGAGGCAGCGGGTCATGT-	NULL
Murine	NULL
JAK3	NULL
was	NULL
cloned	NULL
in	NULL
pRKS	NULL
and	NULL
expressed	NULL
from	NULL
the	NULL
CMV	NULL
promoter	NULL
(	NULL
Witthuhn	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1994	NULL
)	NULL
.	NULL

JAK3AKD	NULL
was	NULL
generated	NULL
by	NULL
insertion	NULL
of	NULL
an	NULL
Xbal	NULL
nonsense	NULL
primer	NULL
(	NULL
#	NULL
NEB1062	NULL
)	NULL
at	NULL
the	NULL
single	NULL
Xhol	NULL
site	NULL
5	NULL
'	NULL
of	NULL
kinase	NULL
domain	NULL
(	NULL
Kawahara	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1995	NULL
)	NULL
.	NULL

Cell	NULL
lines	NULL
The	NULL
cell	NULL
line	NULL
1852.4	NULL
was	NULL
derived	NULL
from	NULL
primary	NULL
human	NULL
B	NULL
cells	NULL
which	NULL
have	NULL
been	NULL
immortalized	NULL
with	NULL
a	NULL
mini-EBV	NULL
plasmid	NULL
carrying	NULL
a	NULL
conditional	NULL
LMP1	NULL
allele	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

1852.4	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
standard	NULL
RPMI	NULL
medium	NULL
containing	NULL
10	NULL
%	NULL
fetal	NULL
calf	NULL
serum	NULL
and	NULL
1	NULL
M	NULL
tetracycline	NULL
as	NULL
described	NULL
(	NULL
Kilger	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1998	NULL
)	NULL
.	NULL

The	NULL
embryonic	NULL
kidney	NULL
cell	NULL
line	NULL
293	NULL
(	NULL
Graham	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1977	NULL
)	NULL
was	NULL
cultured	NULL
in	NULL
standard	NULL
RPMI	NULL
containing	NULL
10	NULL
%	NULL
calf	NULL
serum	NULL
.	NULL

CD4O0-L-expressing	NULL
mouse	NULL
fibroblasts	NULL
are	NULL
described	NULL
by	NULL
Galibert	NULL
et	NULL
al	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
.	NULL

Transfection	NULL
of	NULL
293	NULL
cells	NULL
,	NULL
immunoblots	NULL
and	NULL
immunoprecipitation	NULL
Transfection	NULL
of	NULL
293	NULL
cells	NULL
was	NULL
carried	NULL
out	NULL
in	NULL
six	NULL
well	NULL
plates	NULL
at	NULL
70	NULL
%	NULL
confluency	NULL
.	NULL

Plasmid	NULL
DNAs	NULL
were	NULL
transfected	NULL
using	NULL
Lipofectamin	NULL
(	NULL
Life	NULL
Technologies	NULL
)	NULL
under	NULL
the	NULL
conditions	NULL
recommended	NULL
by	NULL
the	NULL
manufacturer	NULL
.	NULL

Protein	NULL
expression	NULL
was	NULL
assessed	NULL
by	NULL
immunoblot	NULL
analysis	NULL
after	NULL
separation	NULL
by	NULL
10	NULL
%	NULL
SDS-PAGE	NULL
and	NULL
electroblotting	NULL
on	NULL
a	NULL
PVDF	NULL
membrane	NULL
(	NULL
Millipore	NULL
)	NULL
.	NULL

For	NULL
the	NULL
detection	NULL
of	NULL
tyrosine	NULL
phosphorylated	NULL
proteins	NULL
the	NULL
PVDF	NULL
membrane	NULL
was	NULL
first	NULL
incubated	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
RT	NULL
)	NULL
in	NULL
Roti-block	NULL
buffer	NULL
(	NULL
Roth	NULL
)	NULL
and	NULL
then	NULL
in	NULL
a	NULL
1:1	NULL
mixture	NULL
of	NULL
PY20	NULL
and	NULL
4G10	NULL
antibodies	NULL
(	NULL
1	NULL
h	NULL
RT	NULL
)	NULL
.	NULL

Membranes	NULL
were	NULL
then	NULL
washed	NULL
extensively	NULL
and	NULL
incubated	NULL
with	NULL
HRP-conjugated	NULL
&	NULL
-mouse	NULL
immunoglobulin	NULL
secondary	NULL
antibody	NULL
for	NULL
30	NULL
min	NULL
at	NULL
RT	NULL
and	NULL
detected	NULL
with	NULL
the	NULL
enhanced	NULL
chemo-luminescence	NULL
system	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
LMP1	NULL
was	NULL
detected	NULL
using	NULL
biotinylated	NULL
$	NULL
12	NULL
antibody	NULL
(	NULL
1:1000	NULL
in	NULL
TBS-T	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
streptavidin-HRP	NULL
(	NULL
1:500	NULL
)	NULL
and	NULL
ECL	NULL
or	NULL
using	NULL
the	NULL
mix	NULL
of	NULL
monoclonal	NULL
antibodies	NULL
CS1-4	NULL
in	NULL
combination	NULL
with	NULL
HRP-conjugated	NULL
&	NULL
-mouse	NULL
Ig	NULL
antibody	NULL
.	NULL

Alternatively	NULL
,	NULL
FLAG	NULL
epitope-tagged	NULL
variants	NULL
were	NULL
detected	NULL
with	NULL
M2	NULL
@	NULL
-FLAG	NULL
antibody	NULL
(	NULL
IBI-Kodak	NULL
;	NULL
1:300	NULL
in	NULL
TBS-T	NULL
;	NULL
1	NULL
h	NULL
at	NULL
RT	NULL
)	NULL
in	NULL
combination	NULL
with	NULL
HRP-conjugated	NULL
immunoglobulin	NULL
.	NULL

For	NULL
immunoprecipitation	NULL
of	NULL
LMP1	NULL
,	NULL
JAK3	NULL
and	NULL
STAT1	NULL
transiently	NULL
transfected	NULL
293	NULL
cells	NULL
or	NULL
1852.4	NULL
B	NULL
cells	NULL
were	NULL
lysed	NULL
in	NULL
RIPA	NULL
buffer	NULL
containing	NULL
0.1	NULL
mM	NULL
vanadate	NULL
and	NULL
0.5	NULL
mM	NULL
phenylmethylsulfonylfluoride	NULL
(	NULL
PMSF	NULL
)	NULL
,	NULL
and	NULL
the	NULL
protein	NULL
lysates	NULL
were	NULL
precleared	NULL
by	NULL
centrifugation	NULL
at	NULL
15	NULL
300	NULL
r.p.m	NULL
.	NULL

Precleared	NULL
lysates	NULL
were	NULL
then	NULL
incubated	NULL
with	NULL
protein	NULL
G-Sepharose	NULL
beads	NULL
(	NULL
Pharmacia	NULL
)	NULL
coupled	NULL
to	NULL
CS1-4	NULL
(	NULL
Dako	NULL
)	NULL
,	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
or	NULL
STAT1	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
antibodies	NULL
(	NULL
15	NULL
pil	NULL
beads	NULL
+	NULL
10	NULL
pil	NULL
antibody	NULL
for	NULL
200	NULL
pl	NULL
lysate	NULL
from	NULL
105	NULL
cells	NULL
)	NULL
.	NULL

Immunoprecipitation	NULL
was	NULL
carried	NULL
out	NULL
overnight	NULL
at	NULL
4°C	NULL
in	NULL
an	NULL
over-head	NULL
tumbler	NULL
.	NULL

Beads	NULL
were	NULL
then	NULL
washed	NULL
3	NULL
times	NULL
in	NULL
3071	NULL
O.Gires	NULL
et	NULL
al	NULL
.	NULL

TBS-T	NULL
,	NULL
boiled	NULL
,	NULL
centrifuged	NULL
at	NULL
15	NULL
300	NULL
r.p.m	NULL
.	NULL

and	NULL
protein	NULL
expression	NULL
was	NULL
monitored	NULL
by	NULL
Western	NULL
blot	NULL
immunodetection	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Gel	NULL
electromobility	NULL
shift	NULL
assays	NULL
Cells	NULL
were	NULL
lysed	NULL
in	NULL
ice-cold	NULL
lysis	NULL
buffer	NULL
[	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
(	NULL
NP-40	NULL
)	NULL
,	NULL
10	NULL
%	NULL
glycerol	NULL
,	NULL
50	NULL
mM	NULL
Tris-HCI	NULL
pH	NULL
8.0	NULL
,	NULL
150	NULL
mM	NULL
NaCl	NULL
,	NULL
0.1	NULL
M	NULL
EDTA	NULL
pH	NULL
8	NULL
,	NULL
1	NULL
mM	NULL
sodium	NULL
orthovanadate	NULL
,	NULL
0.5	NULL
mM	NULL
PMSF	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
]	NULL
(	NULL
Schindler	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1992	NULL
)	NULL
.	NULL

Nuclei	NULL
were	NULL
removed	NULL
by	NULL
centrifugation	NULL
.	NULL

The	NULL
sequence	NULL
of	NULL
the	NULL
oligonucleotide	NULL
probe	NULL
used	NULL
corresponds	NULL
to	NULL
the	NULL
high-affinity	NULL
sis-inducible	NULL
element	NULL
(	NULL
hSIE	NULL
)	NULL
of	NULL
the	NULL
c-fos	NULL
gene	NULL
(	NULL
SIEM	NULL
)	NULL
:	NULL
5'-GTCGACATTTCCCGTAAATC-3	NULL
'	NULL
(	NULL
Sadowski	NULL
et	NULL
al	NULL
.	NULL

,	NULL
1993	NULL
)	NULL
.	NULL

The	NULL
probe	NULL
was	NULL
end	NULL
labeled	NULL
with	NULL
[	NULL
y-*	NULL
>	NULL
P	NULL
]	NULL
ATP	NULL
and	NULL
aliquots	NULL
equivalent	NULL
to	NULL
30	NULL
000	NULL
c.p.m	NULL
.	NULL

were	NULL
used	NULL
per	NULL
reaction	NULL
.	NULL

Binding	NULL
reactions	NULL
were	NULL
performed	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
20	NULL
pl	NULL
containing	NULL
10	NULL
mM	NULL
HEPES	NULL
pH	NULL
7.9	NULL
,	NULL
1.5	NULL
mM	NULL
MgCl	NULL
,	NULL
0.1	NULL
mM	NULL
EGTA	NULL
,	NULL
5	NULL
%	NULL
glycerol	NULL
,	NULL
1	NULL
mg	NULL
of	NULL
bovine	NULL
serum	NULL
albumin	NULL
per	NULL
ml	NULL
,	NULL
0.25	NULL
mg	NULL
of	NULL
tRNA	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
2	NULL
%	NULL
Ficoll	NULL
.	NULL

Extracts	NULL
were	NULL
preincubated	NULL
for	NULL
5	NULL
min	NULL
at	NULL
RT	NULL
with	NULL
150	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dl-dC	NULL
)	NULL
-	NULL
(	NULL
dl-dC	NULL
)	NULL
per	NULL
ml	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
probe	NULL
for	NULL
an	NULL
additional	NULL
20	NULL
min	NULL
at	NULL
RT	NULL
.	NULL

Complexes	NULL
were	NULL
separated	NULL
on	NULL
6	NULL
%	NULL
non-denaturing	NULL
acrylamide	NULL
gels	NULL
in	NULL
0.5	NULL
%	NULL
Tris-borate-EDTA	NULL
(	NULL
TBE	NULL
)	NULL
and	NULL
detected	NULL
by	NULL
autoradiography	NULL
.	NULL

Acknowledgements	NULL
We	NULL
thank	NULL
the	NULL
members	NULL
of	NULL
the	NULL
Hammerschmidt	NULL
laboratory	NULL
for	NULL
many	NULL
stimulating	NULL
discussions	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

We	NULL
thank	NULL
Bill	NULL
Sugden	NULL
for	NULL
plasmids	NULL
encoding	NULL
various	NULL
LMP1	NULL
and	NULL
JAK	NULL
constructs	NULL
,	NULL
and	NULL
Elisabeth	NULL
Kremer	NULL
for	NULL
the	NULL
supply	NULL
with	NULL
biotinylated	NULL
monoclonal	NULL
antibodies	NULL
against	NULL
LMP1	NULL
.	NULL

Our	NULL
research	NULL
was	NULL
supported	NULL
by	NULL
Grant	NULL
CA70723	NULL
from	NULL
the	NULL
National	NULL
Institutes	NULL
of	NULL
Health	NULL
,	NULL
by	NULL
Grants	NULL
WI	NULL
319/11-3	NULL
and	NULL
Ha	NULL
1354/-2	NULL
from	NULL
the	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
,	NULL
by	NULL
Grant	NULL
1-1016-Ze	NULL
I	NULL
from	NULL
the	NULL
Deutsche	NULL
Krebshilfe	NULL
,	NULL
and	NULL
by	NULL
institutional	NULL
grants	NULL
.	NULL

References	NULL
Baichwal	NULL
,	NULL
V.R	NULL
.	NULL

and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1988	NULL
)	NULL
Transformation	NULL
of	NULL
Balb	NULL
3T3	NULL
cells	NULL
by	NULL
the	NULL
BNLF-I	NULL
gene	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

Oncogene	NULL
,	NULL
2	NULL
,	NULL
461-467	NULL
.	NULL

Briscoe	NULL
,	NULL
J.	NULL
,	NULL
KohThuber	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Miiller	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
JAKs	NULL
and	NULL
STATs	NULL
branch	NULL
out	NULL
.	NULL

Trends	NULL
Cell	NULL
Biol	NULL
.	NULL

,	NULL
6	NULL
,	NULL
336-340	NULL
.	NULL

Catlett-Falcone	NULL
,	NULL
R	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1999	NULL
)	NULL
Constitutive	NULL
activation	NULL
of	NULL
Stat3	NULL
signaling	NULL
confers	NULL
resistance	NULL
to	NULL
apoptosis	NULL
in	NULL
human	NULL
U266	NULL
myeloma	NULL
cells	NULL
.	NULL

Immunity	NULL
,	NULL
10	NULL
,	NULL
105-115	NULL
.	NULL

Cohen	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
protein	NULL
2	NULL
mutations	NULL
define	NULL
essential	NULL
domains	NULL
for	NULL
transformation	NULL
and	NULL
transactivation	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
65	NULL
,	NULL
2545-2554	NULL
.	NULL

Darnell	NULL
,	NULL
J.F	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
STATs	NULL
and	NULL
gene	NULL
regulation	NULL
.	NULL

Science	NULL
,	NULL
277	NULL
,	NULL
1630-1635	NULL
.	NULL

Delecluse	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
Hilsendegen	NULL
,	NULL
T.	NULL
,	NULL
Pich	NULL
,	NULL
D.	NULL
,	NULL
Zeidler	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1998	NULL
)	NULL
Propagation	NULL
and	NULL
recovery	NULL
of	NULL
intact	NULL
,	NULL
infectious	NULL
Epstein-Barr	NULL
virus	NULL
from	NULL
prokaryotic	NULL
to	NULL
human	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
95	NULL
,	NULL
8245-8250	NULL
.	NULL

Delecluse	NULL
,	NULL
H.-J	NULL
.	NULL

,	NULL
Pich	NULL
,	NULL
D.	NULL
,	NULL
Hilsendegen	NULL
,	NULL
T.	NULL
,	NULL
Baum	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1999	NULL
)	NULL
A	NULL
first	NULL
generation	NULL
packaging	NULL
cell	NULL
line	NULL
for	NULL
Epstein-Barr	NULL
derived	NULL
vectors	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
in	NULL
press	NULL
.	NULL

Devergne,0	NULL
.	NULL

,	NULL
Hatzivassiliou	NULL
,	NULL
E.	NULL
,	NULL
Izumi	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Kaye	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Kleijnen	NULL
,	NULL
M.F	NULL
.	NULL

,	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Mosialos	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Association	NULL
of	NULL
TRAF1	NULL
,	NULL
TRAF2	NULL
and	NULL
TRAF3	NULL
with	NULL
an	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
domain	NULL
important	NULL
for	NULL
B-lymphocyte	NULL
transformation	NULL
:	NULL
role	NULL
in	NULL
NF-KB	NULL
activation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
7098-7108	NULL
.	NULL

Eliopoulos	NULL
,	NULL
A.G.	NULL
and	NULL
Rickinson	NULL
,	NULL
A.B	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
LMP1	NULL
masquerades	NULL
as	NULL
an	NULL
active	NULL
receptor	NULL
.	NULL

Curr	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
8	NULL
,	NULL
R196-R198	NULL
.	NULL

Eliopoulos	NULL
,	NULL
and	NULL
Young	NULL
,	NULL
L.S	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Activation	NULL
of	NULL
the	NULL
cJun	NULL
N-terminal	NULL
kinase	NULL
(	NULL
JNK	NULL
)	NULL
pathway	NULL
by	NULL
the	NULL
Epstein-Barr	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
(	NULL
LMP1	NULL
)	NULL
.	NULL

Oncogene	NULL
,	NULL
16	NULL
,	NULL
1731-1742	NULL
.	NULL

Eliopoulos	NULL
,	NULL
Stack	NULL
,	NULL
M.	NULL
,	NULL
Dawson	NULL
,	NULL
C.W	NULL
.	NULL

,	NULL
Kaye	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Hodgkin	NULL
,	NULL
L.	NULL
,	NULL
Sihota	NULL
,	NULL
S8	NULL
.	NULL

,	NULL
Rowe	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Young	NULL
,	NULL
L.S	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Epstein-Barr	NULL
virus-encoded	NULL
LMP1	NULL
and	NULL
CD40	NULL
mediate	NULL
IL-6	NULL
production	NULL
in	NULL
epithelial	NULL
cells	NULL
via	NULL
an	NULL
NF-KB	NULL
pathway	NULL
involving	NULL
TNF	NULL
receptor-associated	NULL
factors	NULL
.	NULL

Oncogene	NULL
,	NULL
14	NULL
,	NULL
2899-2916	NULL
.	NULL

Farrell	NULL
,	NULL
PJ	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
immortalizing	NULL
genes	NULL
.	NULL

Trends	NULL
Microbiol	NULL
.	NULL

,	NULL
3	NULL
,	NULL
105-109	NULL
.	NULL

Flocttmann	NULL
,	NULL
J.E	NULL
.	NULL

and	NULL
Rowe	NULL
,	NULL
M.	NULL
(	NULL
1997	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
C-terminus	NULL
activation	NULL
region	NULL
2	NULL
(	NULL
CTAR2	NULL
)	NULL
maps	NULL
to	NULL
the	NULL
far	NULL
C-terminus	NULL
and	NULL
requires	NULL
oligomerisation	NULL
for	NULL
NF-KB	NULL
activation	NULL
.	NULL

Oncogene	NULL
,	NULL
15	NULL
,	NULL
1851-1858	NULL
.	NULL

Galibert	NULL
,	NULL
L.	NULL
,	NULL
Burdin	NULL
,	NULL
N.	NULL
,	NULL
de	NULL
Saint-Vis	NULL
,	NULL
B.	NULL
,	NULL
Garrone	NULL
,	NULL
P.	NULL
,	NULL
Van	NULL
Kooten	NULL
,	NULL
C.	NULL
,	NULL
Banchereau	NULL
,	NULL
J	NULL
.	NULL

and	NULL
Rousset	NULL
,	NULL
F	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
CD40	NULL
and	NULL
B	NULL
cell	NULL
antigen	NULL
receptor	NULL
3072	NULL
dual	NULL
triggering	NULL
of	NULL
resting	NULL
B	NULL
lymphocytes	NULL
turns	NULL
on	NULL
a	NULL
partial	NULL
germinal	NULL
center	NULL
phenotype	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
183	NULL
,	NULL
77-85	NULL
.	NULL

Gires,0	NULL
.	NULL

,	NULL
Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
Gonnella	NULL
,	NULL
R.	NULL
,	NULL
Ueffing	NULL
,	NULL
M.	NULL
,	NULL
Marschall	NULL
,	NULL
G.	NULL
,	NULL
Zeidler	NULL
,	NULL
R.	NULL
,	NULL
Pich	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
Latent	NULL
membrane	NULL
protein	NULL
1	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
mimics	NULL
a	NULL
constitutively	NULL
active	NULL
receptor	NULL
molecule	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
6131-6140	NULL
.	NULL

Graham	NULL
,	NULL
FL	NULL
.	NULL

,	NULL
Smiley	NULL
,	NULL
J.	NULL
,	NULL
Russell	NULL
,	NULL
W.C.	NULL
and	NULL
Nairn	NULL
,	NULL
R	NULL
.	NULL

(	NULL
1977	NULL
)	NULL
Characteristics	NULL
of	NULL
a	NULL
human	NULL
cell	NULL
line	NULL
transformed	NULL
by	NULL
DNA	NULL
from	NULL
human	NULL
adenovirus	NULL
type	NULL
5	NULL
.	NULL

J.	NULL
Gen	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
36	NULL
,	NULL
59-74	NULL
.	NULL

Hammarskjold	NULL
,	NULL
M.L	NULL
.	NULL

and	NULL
Simurda	NULL
,	NULL
M.C	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
transactivates	NULL
the	NULL
human	NULL
immunodeficiency	NULL
virus	NULL
type	NULL
1	NULL
long	NULL
terminal	NULL
repeat	NULL
through	NULL
induction	NULL
of	NULL
NF-KB	NULL
activity	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
66	NULL
,	NULL
6496-6501	NULL
.	NULL

Hammerschmidt	NULL
,	NULL
W.	NULL
and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1989	NULL
)	NULL
Genetic	NULL
analysis	NULL
of	NULL
immortalizing	NULL
functions	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
,	NULL
340	NULL
,	NULL
393-397	NULL
.	NULL

Hanissian	NULL
,	NULL
S.H	NULL
.	NULL

and	NULL
Geha	NULL
,	NULL
R.S	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Jak3	NULL
is	NULL
associated	NULL
with	NULL
CD40	NULL
and	NULL
is	NULL
critical	NULL
for	NULL
CD40	NULL
induction	NULL
of	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
,	NULL
6	NULL
,	NULL
379-387	NULL
.	NULL

Hatzivassiliou	NULL
,	NULL
E.	NULL
,	NULL
Miller	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
Raab-Traub	NULL
,	NULL
N.	NULL
,	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Mosialos	NULL
,	NULL
G	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
A	NULL
fusion	NULL
of	NULL
the	NULL
EBV	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
transmembrane	NULL
domains	NULL
to	NULL
the	NULL
CD40	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
similar	NULL
to	NULL
LMP1	NULL
in	NULL
constitutive	NULL
activation	NULL
of	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
expression	NULL
,	NULL
nuclear	NULL
factor-KB	NULL
and	NULL
stress-activated	NULL
protein	NULL
kinase	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
160	NULL
,	NULL
1116-1121	NULL
.	NULL

Huen	NULL
,	NULL
D.S	NULL
.	NULL

,	NULL
Henderson	NULL
,	NULL
S.A.	NULL
,	NULL
Croom-Carter	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Rowe	NULL
,	NULL
M	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
(	NULL
LMP1	NULL
)	NULL
mediates	NULL
activation	NULL
of	NULL
NF-KB	NULL
and	NULL
cell	NULL
surface	NULL
phenotype	NULL
via	NULL
two	NULL
effector	NULL
regions	NULL
in	NULL
its	NULL
carboxy-terminal	NULL
cytoplasmic	NULL
domain	NULL
.	NULL

Oncogene	NULL
,	NULL
10	NULL
,	NULL
549-560	NULL
.	NULL

Thle	NULL
,	NULL
J.N	NULL
.	NULL

,	NULL
Witthuhn	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
Quelle	NULL
,	NULL
FEW	NULL
.	NULL

,	NULL
Yamamoto	NULL
,	NULL
K	NULL
.	NULL

and	NULL
Silvennoinen,0	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Signaling	NULL
through	NULL
the	NULL
hematopoietic	NULL
cytokine	NULL
receptors	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
13	NULL
,	NULL
369-398	NULL
.	NULL

Ivashkiv	NULL
,	NULL
L.B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Cytokines	NULL
and	NULL
STATs	NULL
:	NULL
how	NULL
can	NULL
signals	NULL
achieve	NULL
specificity	NULL
?	NULL

Immunity	NULL
,	NULL
3	NULL
,	NULL
1-4	NULL
.	NULL

Izumi	NULL
,	NULL
K.M	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E.D	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
oncogene	NULL
product	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
engages	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor-associated	NULL
death	NULL
domain	NULL
protein	NULL
to	NULL
mediate	NULL
B	NULL
lymphocyte	NULL
growth	NULL
transformation	NULL
and	NULL
activate	NULL
NF-KB	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
94	NULL
,	NULL
12592-12597	NULL
.	NULL

Izumi	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Kaye	NULL
,	NULL
K.M	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E.D	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
amino	NULL
acid	NULL
sequence	NULL
that	NULL
engages	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
associated	NULL
factors	NULL
is	NULL
critical	NULL
for	NULL
primary	NULL
B	NULL
lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
94	NULL
,	NULL
1447-1452	NULL
.	NULL

Karras	NULL
,	NULL
J.G	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
Z.	NULL
,	NULL
Huo	NULL
,	NULL
L.	NULL
,	NULL
Frank	NULL
,	NULL
D.A	NULL
.	NULL

and	NULL
Rothstein	NULL
,	NULL
IL	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Induction	NULL
of	NULL
STAT	NULL
protein	NULL
signaling	NULL
through	NULL
the	NULL
CD40	NULL
receptor	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
distinct	NULL
STAT	NULL
activation	NULL
following	NULL
surface	NULL
Ig	NULL
and	NULL
CD40	NULL
receptor	NULL
engagement	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
159	NULL
,	NULL
4350-4355	NULL
.	NULL

Kawahara	NULL
,	NULL
A.	NULL
,	NULL
Minami	NULL
,	NULL
Y.	NULL
,	NULL
Miyazaki	NULL
,	NULL
T.	NULL
,	NULL
Ihle	NULL
,	NULL
J.N	NULL
.	NULL

and	NULL
Taniguchi	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Critical	NULL
role	NULL
of	NULL
the	NULL
interleukin	NULL
2	NULL
(	NULL
IL-2	NULL
)	NULL
receptor	NULL
y-chain-associated	NULL
Jak3	NULL
in	NULL
the	NULL
IL-2-induced	NULL
c-fos	NULL
and	NULL
c-myc	NULL
,	NULL
but	NULL
not	NULL
bel-2	NULL
,	NULL
gene	NULL
induction	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
92	NULL
,	NULL
8724-8728	NULL
.	NULL

Kaye	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Izumi	NULL
,	NULL
K.M	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
90	NULL
,	NULL
9150-9154	NULL
.	NULL

Kaye	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Izumi	NULL
,	NULL
K.M	NULL
.	NULL

,	NULL
Mosialos	NULL
,	NULL
G	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
cytoplasmic	NULL
carboxy	NULL
terminus	NULL
is	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
transformation	NULL
;	NULL
fibroblast	NULL
cocultivation	NULL
complements	NULL
a	NULL
critical	NULL
function	NULL
within	NULL
the	NULL
terminal	NULL
155	NULL
residues	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
675-683	NULL
.	NULL

Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
and	NULL
its	NULL
replication	NULL
.	NULL

In	NULL
Fields	NULL
,	NULL
B.N	NULL
.	NULL

,	NULL
Knipe	NULL
,	NULL
D.M	NULL
.	NULL

,	NULL
Howley	NULL
,	NULL
P.M.	NULL
,	NULL
Chanock	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Monath	NULL
,	NULL
T.P	NULL
.	NULL

,	NULL
Melnick	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Roizman	NULL
,	NULL
B	NULL
.	NULL

and	NULL
Straus	NULL
,	NULL
S.E	NULL
.	NULL

(	NULL
eds	NULL
)	NULL
,	NULL
Virology	NULL
.	NULL

3rd	NULL
edn	NULL
.	NULL

Lippincott-Raven	NULL
Publishers	NULL
,	NULL
Philadelphia	NULL
,	NULL
PA	NULL
,	NULL
pp	NULL
.	NULL

2343-2396	NULL
.	NULL

Kieser	NULL
,	NULL
A.	NULL
,	NULL
Kilger	NULL
,	NULL
E.	NULL
,	NULL
Gires,0	NULL
.	NULL

,	NULL
Ueffing	NULL
.	NULL

,	NULL
M.	NULL
,	NULL
Kolch	NULL
,	NULL
W.	NULL
and	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
(	NULL
1997	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein-1	NULL
triggers	NULL
AP-1	NULL
activity	NULL
via	NULL
the	NULL
c-Jun	NULL
N-terminal	NULL
kinase	NULL
cascade	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
16	NULL
,	NULL
6478-6485	NULL
.	NULL

Kieser	NULL
,	NULL
A.	NULL
,	NULL
Kaiser	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
W.	NULL
(	NULL
1999	NULL
)	NULL
LMP1	NULL
signal	NULL
transduction	NULL
differs	NULL
substantially	NULL
from	NULL
TNF	NULL
receptor	NULL
1	NULL
signaling	NULL
in	NULL
the	NULL
molecular	NULL
functions	NULL
of	NULL
TRADD	NULL
and	NULL
TRAF2Z	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
18	NULL
,	NULL
2511-2521	NULL
.	NULL

Kilger	NULL
,	NULL
E.	NULL
,	NULL
Kieser	NULL
,	NULL
A.	NULL
,	NULL
Baumann	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
Epstein-Barr	NULL
virus-mediated	NULL
B-cell	NULL
proliferation	NULL
is	NULL
dependent	NULL
upon	NULL
latent	NULL
membrane	NULL
protein	NULL
1	NULL
,	NULL
which	NULL
simulates	NULL
an	NULL
activated	NULL
CD40	NULL
receptor	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
17	NULL
,	NULL
1700-1709	NULL
.	NULL

Laherty	NULL
,	NULL
C.D	NULL
.	NULL

,	NULL
Hu	NULL
,	NULL
H.M.	NULL
,	NULL
Opipari	NULL
,	NULL
A.W	NULL
.	NULL

,	NULL
Wang	NULL
,	NULL
F	NULL
.	NULL

and	NULL
Dixit	NULL
,	NULL
V.M	NULL
.	NULL

(	NULL
1992	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
gene	NULL
product	NULL
induces	NULL
A20	NULL
zinc	NULL
finger	NULL
protein	NULL
expression	NULL
by	NULL
activating	NULL
nuclear	NULL
factor	NULL
xB	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

,	NULL
267	NULL
,	NULL
24157-24160	NULL
.	NULL

Leonard	NULL
,	NULL
W.	NULL
and	NULL
O'Shea	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1998	NULL
)	NULL
JAKs	NULL
and	NULL
STATs	NULL
:	NULL
Biological	NULL
Implications	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
16	NULL
,	NULL
293-322	NULL
.	NULL

Liecbowitz	NULL
,	NULL
D.	NULL
,	NULL
Wang	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1986	NULL
)	NULL
Orientation	NULL
and	NULL
patching	NULL
of	NULL
the	NULL
latent	NULL
infection	NULL
membrane	NULL
protein	NULL
encoded	NULL
by	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
58	NULL
,	NULL
233-237	NULL
.	NULL

Macchi	NULL
,	NULL
P	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mutations	NULL
of	NULL
Jak-3	NULL
gene	NULL
in	NULL
patients	NULL
with	NULL
autosomal	NULL
severe	NULL
combined	NULL
immune	NULL
deficiency	NULL
(	NULL
SCID	NULL
)	NULL
.	NULL

Nature	NULL
,	NULL
377	NULL
,	NULL
65-68	NULL
.	NULL

Miller	NULL
,	NULL
W.E	NULL
.	NULL

,	NULL
Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Raab-Traub	NULL
,	NULL
N	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
LMP1	NULL
induction	NULL
of	NULL
the	NULL
epidermal	NULL
growth	NULL
factor	NULL
receptor	NULL
is	NULL
mediated	NULL
through	NULL
a	NULL
TRAF	NULL
signaling	NULL
pathway	NULL
distinct	NULL
from	NULL
NF-KB	NULL
activation	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
71	NULL
,	NULL
586-594	NULL
.	NULL

Mitchell	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Stimulation	NULL
of	NULL
NF-KB-mediated	NULL
transcription	NULL
by	NULL
mutant	NULL
derivatives	NULL
of	NULL
the	NULL
latent	NULL
membrane	NULL
protein	NULL
of	NULL
Epstein-Barr	NULL
virus	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
69	NULL
,	NULL
2968-2976	NULL
.	NULL

Moorthy	NULL
,	NULL
R.K	NULL
.	NULL

and	NULL
Thorley-Lawson	NULL
,	NULL
D.A	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
All	NULL
three	NULL
domains	NULL
of	NULL
the	NULL
Epstein-Barr	NULL
virus-encoded	NULL
latent	NULL
membrane	NULL
protein	NULL
LMP-1	NULL
are	NULL
required	NULL
for	NULL
transformation	NULL
of	NULL
rat-l	NULL
fibroblasts	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
1638-1646	NULL
.	NULL

Mosialos	NULL
,	NULL
G.	NULL
,	NULL
Birkenbach	NULL
,	NULL
M.	NULL
,	NULL
Yalamanchili	NULL
,	NULL
R.	NULL
,	NULL
VanArsdale	NULL
,	NULL
T.	NULL
,	NULL
Ware	NULL
,	NULL
C	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
The	NULL
Epstein-Barr	NULL
virus	NULL
transforming	NULL
protein	NULL
LMP1	NULL
engages	NULL
signaling	NULL
proteins	NULL
for	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
receptor	NULL
family	NULL
.	NULL

Cell	NULL
,	NULL
80	NULL
,	NULL
389-399	NULL
.	NULL

Murakami	NULL
,	NULL
M.	NULL
,	NULL
Narazaki	NULL
,	NULL
M.	NULL
,	NULL
Hibi	NULL
,	NULL
M.	NULL
,	NULL
Yawata	NULL
,	NULL
H.	NULL
,	NULL
Yasukawa	NULL
,	NULL
K.	NULL
,	NULL
Hamaguchi	NULL
,	NULL
M.	NULL
,	NULL
Taga	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Kishimoto	NULL
,	NULL
T	NULL
.	NULL

(	NULL
1991	NULL
)	NULL
Critical	NULL
cytoplasmic	NULL
region	NULL
of	NULL
the	NULL
interleukin	NULL
6	NULL
signal	NULL
transducer	NULL
gp130	NULL
is	NULL
conserved	NULL
in	NULL
the	NULL
cytokine	NULL
receptor	NULL
family	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
,	NULL
88	NULL
,	NULL
11349-11353	NULL
.	NULL

Murata	NULL
,	NULL
T	NULL
.	NULL

and	NULL
Puri	NULL
,	NULL
R.K	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Comparison	NULL
of	NULL
IL-13-	NULL
and	NULL
IL-4-induced	NULL
signaling	NULL
in	NULL
EBV-immortalized	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
175	NULL
,	NULL
33-40	NULL
.	NULL

Rodriguez	NULL
Tarduchy	NULL
,	NULL
G.	NULL
,	NULL
-	NULL
Collins	NULL
,	NULL
M	NULL
.	NULL

-	NULL
and	NULL
-	NULL
Lopez	NULL
Rivas	NULL
,	NULL
A	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Regulation	NULL
of	NULL
apoptosis	NULL
in	NULL
interleukin-3-dependent	NULL
hemopoietic	NULL
cells	NULL
by	NULL
interleukin-3	NULL
and	NULL
calcium	NULL
ionophores	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
9	NULL
,	NULL
2997-3002	NULL
.	NULL

Russell	NULL
,	NULL
S.M	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Mutation	NULL
of	NULL
JAK3	NULL
in	NULL
a	NULL
patient	NULL
with	NULL
SCID	NULL
:	NULL
essential	NULL
role	NULL
of	NULL
JAK3	NULL
in	NULL
lymphoid	NULL
development	NULL
.	NULL

Science	NULL
,	NULL
270	NULL
,	NULL
797-800	NULL
.	NULL

Sadowski	NULL
,	NULL
H.B	NULL
.	NULL

,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Darnell	NULL
,	NULL
J.F	NULL
.	NULL

,	NULL
Jr	NULL
and	NULL
Gilman	NULL
,	NULL
M.Z	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
A	NULL
common	NULL
nuclear	NULL
signal	NULL
transduction	NULL
pathway	NULL
activated	NULL
by	NULL
growth	NULL
factor	NULL
and	NULL
cytokine	NULL
receptors	NULL
.	NULL

Science	NULL
,	NULL
261	NULL
,	NULL
1739-1744	NULL
.	NULL

Sandberg	NULL
,	NULL
M.	NULL
,	NULL
Hammerschmidt	NULL
,	NULL
W.	NULL
and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1997	NULL
)	NULL
Characterization	NULL
of	NULL
LMP-1	NULL
's	NULL
association	NULL
with	NULL
TRAFL	NULL
,	NULL
TRAF2	NULL
and	NULL
TRAF3	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
71	NULL
,	NULL
4649-4656	NULL
.	NULL

Schindler	NULL
,	NULL
C.	NULL
,	NULL
Shuai	NULL
,	NULL
K.	NULL
,	NULL
Prezioso	NULL
,	NULL
V.R	NULL
.	NULL

and	NULL
Damell	NULL
,	NULL
J.E..Jr	NULL
(	NULL
1992	NULL
)	NULL
Interferon-dependent	NULL
tyrosine	NULL
phosphorylation	NULL
of	NULL
a	NULL
latent	NULL
cytoplasmic	NULL
transcription	NULL
factor	NULL
.	NULL

Science	NULL
,	NULL
257	NULL
,	NULL
809-813	NULL
.	NULL

Silvennoinen,0	NULL
.	NULL

,	NULL
Thle	NULL
,	NULL
J.N	NULL
.	NULL

,	NULL
Schlessinger	NULL
,	NULL
)	NULL
.	NULL

and	NULL
Levy	NULL
,	NULL
D.E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Interferon-induced	NULL
nuclear	NULL
signalling	NULL
by	NULL
Jak	NULL
protein	NULL
tyrosine	NULL
kinases	NULL
.	NULL

Nature	NULL
,	NULL
366	NULL
,	NULL
583-585	NULL
.	NULL

Tomkinson	NULL
,	NULL
B.	NULL
,	NULL
Robertson	NULL
,	NULL
E	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1993	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
nuclear	NULL
proteins	NULL
EBNA-3A	NULL
and	NULL
EBNA-3C	NULL
are	NULL
essential	NULL
for	NULL
B-lymphocyte	NULL
growth	NULL
transformation	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
67	NULL
,	NULL
2014-2025	NULL
.	NULL

Tortolani	NULL
,	NULL
P.J	NULL
.	NULL

et	NULL
al	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Regulation	NULL
of	NULL
JAK3	NULL
expression	NULL
and	NULL
activation	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
and	NULL
B	NULL
cell	NULL
malignancies	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
155	NULL
,	NULL
5220-5226	NULL
.	NULL

Tosato	NULL
,	NULL
G.	NULL
,	NULL
Tanner	NULL
,	NULL
J.	NULL
,	NULL
Jones	NULL
,	NULL
K.D	NULL
.	NULL

,	NULL
Revel	NULL
,	NULL
M	NULL
.	NULL

and	NULL
Pike	NULL
,	NULL
S.E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Identification	NULL
of	NULL
interleukin-6	NULL
as	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
for	NULL
Epstein-Barr	NULL
virus-immortalized	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
3033-3041	NULL
.	NULL

Wang	NULL
,	NULL
D.	NULL
,	NULL
Licbowitz	NULL
,	NULL
D	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
An	NULL
EBV	NULL
membrane	NULL
protein	NULL
expressed	NULL
in	NULL
immortalized	NULL
lymphocytes	NULL
transforms	NULL
established	NULL
rodent	NULL
cells	NULL
.	NULL

Cell	NULL
,	NULL
43	NULL
,	NULL
831-840	NULL
.	NULL

Wang	NULL
,	NULL
F.	NULL
,	NULL
Gregory	NULL
,	NULL
C.	NULL
,	NULL
Sample	NULL
,	NULL
C.	NULL
,	NULL
Rowe	NULL
,	NULL
M.	NULL
,	NULL
Liecbowitz	NULL
,	NULL
D.	NULL
,	NULL
Murray	NULL
,	NULL
R.	NULL
,	NULL
Rickinson	NULL
,	NULL
A	NULL
.	NULL

and	NULL
Kieff	NULL
,	NULL
E	NULL
.	NULL

(	NULL
1990	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
and	NULL
nuclear	NULL
proteins	NULL
2	NULL
and	NULL
3C	NULL
are	NULL
effectors	NULL
of	NULL
phenotypic	NULL
changes	NULL
in	NULL
B	NULL
lymphocytes	NULL
:	NULL
EBNA-2	NULL
and	NULL
LMP1	NULL
cooperatively	NULL
induce	NULL
CD23	NULL
.	NULL

J	NULL
.	NULL

Virol	NULL
.	NULL

,	NULL
64	NULL
,	NULL
2309-2318	NULL
.	NULL

Weber-Nordt	NULL
,	NULL
R.M	NULL
.	NULL

,	NULL
Egen	NULL
,	NULL
C.	NULL
,	NULL
Wehinger	NULL
,	NULL
J.	NULL
,	NULL
Ludwig	NULL
,	NULL
W.	NULL
,	NULL
Gouilleux-Gruart	NULL
,	NULL
V.	NULL
,	NULL
Mertelsmann	NULL
,	NULL
R	NULL
.	NULL

and	NULL
Finke	NULL
,	NULL
J	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Constitutive	NULL
activation	NULL
of	NULL
STAT	NULL
proteins	NULL
in	NULL
primary	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
and	NULL
in	NULL
Epstein-Barr	NULL
virus	NULL
(	NULL
EBV	NULL
)	NULL
-related	NULL
lymphoma	NULL
cell	NULL
lines	NULL
.	NULL

Blood	NULL
,	NULL
88	NULL
,	NULL
809-816	NULL
.	NULL

Witthuhn	NULL
,	NULL
B.A	NULL
.	NULL

,	NULL
Silvennoinen,0	NULL
.	NULL

,	NULL
Miura,0	NULL
.	NULL

,	NULL
Lai	NULL
,	NULL
K.S	NULL
.	NULL

,	NULL
Cwik	NULL
,	NULL
C.	NULL
,	NULL
Liy	NULL
,	NULL
E.T	NULL
.	NULL

and	NULL
Ihle	NULL
,	NULL
J.N	NULL
.	NULL

(	NULL
1994	NULL
)	NULL
Involvement	NULL
of	NULL
the	NULL
Jak-3	NULL
Janus	NULL
kinase	NULL
in	NULL
signalling	NULL
LMP1	NULL
activates	NULL
JAK/STAT	NULL
by	NULL
interleukins	NULL
2	NULL
and	NULL
4	NULL
in	NULL
lymphoid	NULL
and	NULL
myeloid	NULL
cells	NULL
.	NULL

Nature	NULL
,	NULL
370	NULL
,	NULL
153-157	NULL
.	NULL

Xu	NULL
,	NULL
X.	NULL
,	NULL
Kang	NULL
,	NULL
S.H	NULL
.	NULL

,	NULL
Heidenreich,0	NULL
.	NULL

,	NULL
Okerholm	NULL
,	NULL
M.	NULL
,	NULL
O'Shea	NULL
,	NULL
J.J	NULL
.	NULL

and	NULL
Nerenberg	NULL
,	NULL
ML	NULL
.	NULL

(	NULL
1995	NULL
)	NULL
Constitutive	NULL
activation	NULL
of	NULL
different	NULL
Jak	NULL
tyrosine	NULL
kinases	NULL
in	NULL
human	NULL
T	NULL
cell	NULL
leukemia	NULL
virus	NULL
type	NULL
1	NULL
(	NULL
HTLV-1	NULL
)	NULL
tax	NULL
protein	NULL
or	NULL
virus-transformed	NULL
cells	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

,	NULL
96	NULL
,	NULL
1548-1555	NULL
.	NULL

Yates	NULL
,	NULL
J.L	NULL
.	NULL

,	NULL
Warren	NULL
,	NULL
N	NULL
.	NULL

and	NULL
Sugden	NULL
,	NULL
B	NULL
.	NULL

(	NULL
1985	NULL
)	NULL
Stable	NULL
replication	NULL
of	NULL
plasmids	NULL
derived	NULL
from	NULL
Epstein-Barr	NULL
virus	NULL
in	NULL
various	NULL
mammalian	NULL
cells	NULL
.	NULL

Nature	NULL
,	NULL
313	NULL
,	NULL
812-815	NULL
.	NULL

Zimber-Strobl	NULL
,	NULL
U.	NULL
,	NULL
Kempkes	NULL
,	NULL
B.	NULL
,	NULL
Marschall	NULL
,	NULL
G.	NULL
,	NULL
Zeidler	NULL
,	NULL
R.	NULL
,	NULL
Van	NULL
Kooten	NULL
,	NULL
C.	NULL
,	NULL
Banchereau	NULL
,	NULL
J.	NULL
,	NULL
Bornkamm	NULL
,	NULL
G.W	NULL
.	NULL

and	NULL
Hammerschmidt	NULL
,	NULL
W	NULL
.	NULL

(	NULL
1996	NULL
)	NULL
Epstein-Barr	NULL
virus	NULL
latent	NULL
membrane	NULL
protein	NULL
(	NULL
LMP1	NULL
)	NULL
is	NULL
not	NULL
sufficient	NULL
to	NULL
maintain	NULL
proliferation	NULL
of	NULL
B-cells	NULL
but	NULL
both	NULL
it	NULL
and	NULL
activated	NULL
CD40	NULL
can	NULL
prolong	NULL
their	NULL
survival	NULL
.	NULL

EMBO	NULL
J.	NULL
,	NULL
15	NULL
,	NULL
7070-7078	NULL
.	NULL

Received	NULL
November	NULL
9	NULL
,	NULL
1998	NULL
;	NULL
revised	NULL
and	NULL
accepted	NULL
April	NULL
13	NULL
,	NULL
1999	NULL
3073	NULL

